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ABSTRACT
LYSOSOMAL EVASION OF LEGIONELLA PNEUMOPHILA BY THE
EFFECTOR MAVE

Bethany Vaughn
April 22, 2022
Legionella pneumophila is a Gram-negative facultative intracellular bacterium found in
freshwater environments that has co-evolved to survive and proliferate in various amoeba and
protozoan species, which serve as the natural host for the bacterium. Humans are an accidental
host of L. pneumophila, where infection occurs upon inhalation of aerosolized water droplets that
contain the bacteria. Intracellular proliferation of L. pneumophila in alveolar macrophages is
essential for manifestation of pneumonia, designated as Legionnaires’ Disease. Biogenesis of
the legionella containing vacuole (LCV) occurs via interception of ER-Golgi vesicle trafficking
and avoids the default endosomal/lysosomal degradation pathway. Intracellular proliferation of
L. pneumophila within protozoa and macrophages is dependent on the Dot/Icm type IV secretion
system (T4SS) apparatus, which is comprised of 27 proteins and is responsible for translocating
over 350 different effector proteins into the host cell. Many of these effector proteins contain
eukaryotic-like domains and motifs, which have been acquired through interkingdom horizontal
gene transfer from various aquatic eukaryotic hosts. While L. pneumophila contains the largest
repertoire of effector proteins, known for an intracellular pathogen, most of which are not
required for survival and proliferation in mammalian macrophages. It is more likely that the
large repertoire of effector proteins constitutes a toolbox utilized by L. pneumophila to survive
and replicate within various protozoan species. The diversion of the L. pneumophila-containing
v

vacuole (LCV) from the host endosomal-lysosomal degradation pathway is one of the main
virulence features essential for disease manifestation. Many of the ~350 Dot/Icm-injected
effectors identified in L. pneumophila have been shown to interfere with various host pathways
and processes; but no L. pneumophila effector has ever been identified to be indispensable for
lysosomal evasion.
While most effector mutants of L. pneumophila do not exhibit a defective phenotype
within macrophages, we show that the MavE effector is essential for intracellular growth of L.
pneumophilia in human monocyte-derived macrophages (hMDMs), amoebae and for
intrapulmonary proliferation in mice. This is shown by both single cell analysis during confocal
microscopy and by quantifying colony forming units (CFUs). We have shown the mavE null
mutant fails to remodel the LCV with ER-derived vesicles and is trafficked to the lysosomes
where it is degraded, similar to formalin-killed bacteria. Importantly, during infection of
hMDMs, the MavE effector localizes to the poles of the LCV membrane.
The crystal structure of MavE (39-172) was resolved to 1.8 Å, revealing a eukaryotic
NPxY motif that binds with phosphotyrosine-binding domains present on signaling and adaptor
eukaryotic proteins. We show that point mutations within the NPxY motif results in attenuation
of L. pneumophila in both hMDMs and amoeba, and the substitution defects of P 78 and D64
results in fusion of the LCV to the lysosomes, with no remodeling by the ER, leading to bacterial
degradation.
Following ectopic expression of MavE, a proximity-dependent biotin identification
(BioID) strategy was used to screen for MavE-interacting proteins in mammalian cells. These
data show that MavE interacts with a host protein, acyl-CoA binding domain containing 3
(ACBD3), which co-localizes with the LCV. ACBD3 plays an essential role in the sorting and
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modification of proteins exported from the endoplasmic reticulum through its interaction with
the integral membrane protein giantin. We have shown the mavE null mutant-containing LCV
fails to colocalize with ACBD3, similar to the Dot/Icm translocation-defective mutant. There are
areas of homology of ACBD3 with proteins found in Amoebozoa, indicative of a possible
conserved binding motif. We conclude that the MavE effector of L. pneumophila is
indispensable for phagosome biogenesis and lysosomal evasion by interacting with the host
protein ACBD3, which is involved in ER-Golgi vesicle trafficking and is likely conserved
throughout evolution.
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CHAPTER 1:
INTRODUCTION
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INTRODUCTION
Discovery of Legionnaires’ Disease and Etiological Aspects
In the summer of 1976, approximately 4,000 American Legion delegates attended
the 58th annual American Legion Convention in Philadelphia, Pennsylvania. Within 2
weeks of the convention, 180 attendees suffered from pneumonia-like symptoms of
which 29 had succumbed to the atypical pneumonia. Most of the victims had visited the
Bellevue Stratford, a grand hotel on Broad Street that had hosted the convention on July
21–24. However, a bus driver and several pedestrians passing by the hotel were part of
the same outbreak. Nicknamed the “Philly Killer,” a total of 34 persons were confirmed
to have died from the illness and a total of 221 had become ill [1, 2].
Initially, a physician in Philadelphia telephoned the Centers for Disease Control
and Prevention (CDC), fearing that this disease was caused by a new strain of influenza
identified just 6 months prior. However, within days of arriving at the Bellevue hotel, the
CDC ruled out influenza as the causative agent. The investigation of the unidentified
infectious agent lasted close to six months and was worked on by multiple teams of
parasitologists, virologists, epidemiologists, bacteriologists, and toxicologists. In January
1977, the causative agent was identified by Joseph McDade while examining smears of
liver sections from guinea pigs inoculated with lung tissue from Legionnaires' patients.
McDade noticed occasional clusters of peculiar rod-shaped bacteria; these were called
Legionnaires’ Disease bacterium until April 1979. Then the bacteria were given the
name, Legionella pneumophila representing the disease caused as well as those who were
affected by the first documented outbreak, the attendees of the American Legion
Convention [2-4]. It was later suspected that the Stratford hotel air conditioning was
2

contaminated with Legionella pneumophila as the specific source for the 1976 outbreak,
however, environmental tests for Legionella were not yet developed, so the exact source
remains unknown [5].
L. pneumophila is a global pathogen and existed prior to the 1976 outbreak. The
number of cases has been on the rise since early 2000’s with nearly 10,000 cases of
Legionnaires’ disease reported in the United States alone in 2018 [6]. Bacteria of the
genus Legionella comprises 65 species with the primary causative agent of Legionnaires’
disease being L. pneumophila. However, largely reported cases of disease in Australia
and New Zealand are attributable to Legionella longbeachae [7]. The species L.
pneumophila can be subdivided into 16 serogroups and confirmed human infection is
caused primarily by serogroup 1 but infections with other serogroups, including 3, 4, and
6 have been reported [7-11]. Serogroup 1 is the most virulent strain causing 80-90% of
laboratory confirmed legionellosis cases [12]. Legionellosis occurs most commonly
when bacilli from the genus Legionella is present in a contaminated water source is
aerosolized and inhaled [13]. Such contaminated water sources include but are not
limited to air conditioning cooling towers, grocery misters, decorative fountains, and hot
tubs.

Clinical Manifestations of L. pneumophila
Once Legionella reaches the lung, clinical presentation of the infection results in
two distinct disorders, Legionnaires’ disease or Pontiac Fever [13]. Legionnaires’
disease is a severe, often fatal pneumonia associated with fever, chills, cough, lethargy,
headache, muscle aches, sometimes with extrapulmonary manifestations such as renal
3

failure, encephalopathy, and pericarditis. [13]. Pontiac Fever, named after the 1968
outbreak in Pontiac, Michigan, is a febrile flu-like illness which usually resolves in 2 to 5
days with no pneumonia or mortality and does not benefit from any treatment with
antibiotics [13]. Both Pontiac fever and the more severe Legionnaire’s disease maybe
caused by the same bacteria and serogroups, but Pontiac fever resembles acute influenza
with no pneumonia [14, 15]. Why Pontiac fever has less severe manifestations than
Legionnaires’ disease is not yet understood.
Legionnaires’ disease can be very serious with a 10-15% mortality rate and can
reach as much as 25-50% in immunocompromised and immunosuppressed patients [16].
Older people, immune compromised individuals, smokers, and people with underlying
lung disease are more susceptible to Legionnaires’ disease. While healthy individuals are
also at risk for contracting the disease, they might not have any symptoms or only
experience a mild illness [13, 16-18]. Community-acquired pneumonia (CAP) is an acute
infection of the pulmonary parenchyma that develops in persons outside of a
hospital/healthcare facility [19]. CAP is the leading cause of morbidity and mortality in
high- and low-income countries [20]. Recently, studies have identified Legionella
species as being among the top 3 microbial causes of hospitalization due to CAP [21].
However, the exact incidence of Legionnaires’ disease is unknown due to the difference
in surveillance, reporting, and diagnostic methods [20, 21]. In more than 50% of cases of
pneumonia, the causative organism is not known [22].
Symptoms of Legionnaires’ disease usually appear within 2 to 10 days after
exposure, with an average of onset 5 to 6 days after exposure [23]. Symptoms usually
appear much sooner for Pontiac fever, appearing in just 5 to 72 hours [24]. Patients with
4

a more severe form of the disease may show gastrointestinal symptoms including
diarrhea, bloody sputum, vomiting, and abdominal pain [25-27]. Patients that succumb to
the disease generally die as result of multi organ failure or respiratory shock [28]. No
vaccines exist to protect from Legionnaires’ disease, but instead can be treated with
recommended classes of antibiotics including fluoroquinolones, macrolides, and rifampin
[29-31]. However, macrolides are not recommended to treat immunocompromised
patients as they can interfere with immunosuppressant agents. Also, treatment with
penicillin and β-lactams is not recommended due to L. pneumophila being resistant to
these antibiotics [32-34].
Legionnaires’ disease is substantially underdiagnosed and under-reported in many
countries because of a lack of diagnostics and surveillance systems [35-37]. Data from
the USA indicated a 249% increase in estimated national incidence of Legionnaires’
disease from 2000 to 2011 [25, 38]. The yearly incidence of Legionnaires’ disease seems
to be associated with climate changes and subject to seasonal variations with humidity
and rainfall resulting in increased aerosol transmission, with 62% of cases occurring
during summer and early autumn [39, 40]. Often when patients present with pneumonia,
antibiotics are used, and no lab diagnostic tests are performed to determine the causative
agent of the pneumonia. However, the German Competence Network for CommunityAcquired Pneumonia has set out to standardize microbiology protocols for extensive
testing to diagnose Legionella pneumonia [41]. The study reported a prevalence of 180360 cases per million inhabitants and extrapolating this data to the numbers reported in
the USA, cases of Legionnaires’ disease reported to the CDC most likely represent less
than 5% of actual cases [41]. Highly sensitive urine-ELISA assays are commonly being
5

used to detect all Legionella species, yielding isolates for additional characterization [4244]. However, only sequence-based schemes have the necessary resolution to speciate or
recognize potentially novel strains of Legionella [45]. Without consistent patient testing
that is subject to skill, experience, and procedural rigor of the laboratory, it is difficult to
confirm the number of Legionnaires’ disease cases annually. Importantly, proper
diagnosis is needed for treatment worldwide and the rates reported likely underestimate
the actual disease burden of legionellosis.

Epidemiology of L. pneumophila
Outbreaks of L. pneumophila first emerged in the 20th century as a result of
human alterations to the environment such as cooling towers or plumbing in large
buildings [10]. L. pneumophila are an important public health problem as they are
ubiquitous in globally distributed aquatic habitats and water distribution systems.
Legionellae would be an extremely rare cause of human disease if left in their natural
state, however inhalation of contaminated aerosolized water droplets often are traced to
human-made aquatic environments [10, 46-49]. A single exception to this is Legionella
longbeachae, a frequent isolate from potting soil [10, 50]. While L. pneumophila is
typically an environmental pathogen, person-to-person transmission does not occur in
most cases with the exception of one rare, reported case in 2014 [51]. The very close
contact that occurred between patient 0 (a smoker that had worked at an industrial
cooling tower complex) and patient 1 (an elderly woman that cared for patient 0 in a
nonventilated room before being transported to the hospital) most likely attributed to the
transmission [51-53].
6

Members of the Legionella species have been detected by Polymerase Chain
Reaction (PCR) in up to 80% of freshwater environments worldwide and has become the
most identified drinking water pathogen [10, 54]. Species of Legionella are ubiquitous to
many freshwater environments and man-made water systems around the world. L.
pneumophila multiplies at temperatures between 25-42ᵒC, and thermally altered aquatic
environments can result in rapid multiplication of the bacteria [55]. L. pneumophila can
be controlled in water handling systems with proper maintenance, however some
municipal drinking water systems have summertime water temperatures that favor
Legionella growth [50]. For eradication, continual water treatment is required, although
monitoring for Legionella in potable water systems in not required by any state or federal
regulations [50]. Control measures to prevent bacterial intrusion, growth, and
transmission include monitoring temperature, maintaining hot water tanks at temperatures
above 60ºC, disinfecting with either monochloramine, chlorine dioxides, or copper-silver
ions and checking pH frequently [56-58]. Remediation however is generally tailored to
the circumstances of the risk of Legionella growth and transmission. Therefore,
treatment of contaminated water sources includes biocides, boiling water, UV irradiation,
and using 0.2-micron biological point-of-use (POU) filters. However, these methods
provide temporal solutions and are not successful for eradicating the bacteria from water
sources [56, 57, 59-61]. The protection of L. pneumophila within biofilms and amoeba
contributes to the bacterial survival, allowing for re-colonization within months of
disinfection [62].
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Molecular Ecology of L. pneumophila and its Intracellular Life Cycle within
Protozoa
While Legionellae can survive in aquatic and moist soil environments, protozoa
are an important reservoir for supporting growth of legionellae in aquatic environments
[63]. Remarkably, L. pneumophila resist digestion by amoebae that are natural microbial
predators in the environment. L. pneumophila is a facultative intracellular parasite of 17
known species of amoebae and 7 species of non-amoebal protozoa [64-78]. When
Legionella invades amoebae, it forms a unique protective single-membrane replicative
vacuole that does not mature through the default endosomal-lysosomal degradation
pathway [10, 79-81]. This association of Legionellae with protozoa is a major factor in
bacterial amplification and persistence in the environment, ultimately enhancing its
pathogenicity [82, 83].
The relationship between L. pneumophila and amoebae plays an important role in
the persistence of bacterium in the environment and contributes to resistance in bacterial
eradication. Under harmful and/or unfavorable environments, the trophozoite form of
protozoa can differentiate into a spore-like dormant cyst to ensure their survival, but the
cyst restricts intracellular growth of L. pneumophila [84]. However, Legionella spp. have
developed the ability to resist and survive within an amoebic cyst for at least 6 months
[85-88]. Interestingly, L. pneumophila has evolved to subvert amoebal encystation by
secreting the effector protein LamA, an amylase, which degrades host cell glycogen,
which is the main resource for synthesis of the cellulose double-wall of the cyst [89].
Another supportive finding that amoeba plays a key role in the ecology and
pathogenesis of L. pneumophila is discovery of Legionella-like amoebal pathogens
8

(LLAPs) [90, 91]. LLAPs are phylogenetically related to Legionella and have been
associated with Legionnaires’ disease, playing a role in CAP [92-94]. While LLAP
rRNA shows a 95% similarity to L. pneumophila rRNA, LLAPs cannot be cultured in
vitro on artificial media but are readily isolated by coculture with protozoa, highlighting
the importance protozoa play in the transmission of Legionella species [92, 95].
Transcriptional analysis of L. pneumophila during infection of Acanthamoeba
castellanii showed that there are two phenotypic bacterial phases existing both in vivo
and in vitro [96]. One morphological form of L. pneumophila is a replicative rod-shaped
form, and the second, a motile coccoid-shaped Mature Intracellular Form (MIF)
developed upon egress from the spent protozoan host [97-99]. The MIF form features a
distinct thickened cell wall, multilayer membrane laminations and Poly-3Hydroxybutyrate [PHB] inclusions ideal for long-term survival between protozoan hosts
[100]. Respirable sized vesicles containing L. pneumophila are released from protozoa
and are highly resistant to biocides, sonication, and freezing [101]. When released from a
protozoan host, L. pneumophila exhibits an enhanced ability to infect mammalian cells
compared to agar grown bacteria [102]. The biochemical and physiological change
observed in protozoan grown L. pneumophila has promoted its ability to infect human
macrophages [103-105]. The progeny that escapes from lysed amoebae are highly motile
with an increase in uptake by phagocytosis with increased resistance to antibiotics,
biocides, and disinfectants [103-105]. The co-evolution of Legionella within protozoa
have facilitated survival and proliferation of L. pneumophila within the evolutionary
distant human macrophage.
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Protozoa play a crucial role in the lifecycle of Legionella colonization and
persistence in its natural environment and are associated with biofilm formation. Biofilm
formation promotes the survival of L. pneumophila [106]. Interestingly, several amoeba
species are associated with biofilm communities, and the amount of L. pneumophila in
biofilms is directly correlated with the biomass of protozoa [107, 108]. The biofilm
structure or its association with amoeba make L. pneumophila containing biofilms
extremely resilient to treatment with biocides [109]. Legionellae exposed to
environmental stresses and/or found within biofilms are also able to enter a Viable But
Non Culturable cell state (VBNC) [110]. VBNC Legionella show low metabolic activity
but can be resuscitated within amoebae after co-culture [111]. The VBNC state allows
survival and adaptation of Legionella to commonly used preventative and control
practices of water sources such as chlorination [110].

Intracellular Life Cycle of L. pneumophila within Macrophages
Protozoa are the natural host for L. pneumophila while humans are considered an
accidental host. The ability of L. pneumophila to infect human macrophages is
hypothesized to be a consequence of prior adaptation to an intracellular life within its
natural protozoan hosts [112]. Accidental infection of humans occurs when an individual
inhales water contaminated with Legionella spp. [10, 80]. Once L. pneumophila infects a
human host it enters through conventional or coiling phagocytosis into alveolar
macrophages where the intracellular life cycle is strikingly similar to the life cycle
observed when amoebae engulf L. pneumophila [10, 80, 113, 114]. Once inside the host
cell, the bacteria can be found inside a unique single-membrane replicative vacuole [81].
10

The vacuole differs from the vacuolar compartment of avirulent bacteria in that it does
not acidify and evades the endosomal-lysosomal degradation pathway [115]. The
vacuole intercepts ER-to-Golgi vesicle traffic to become an ER-derived vacuole [10, 116118]. This vacuole is termed the L. pneumophila Containing Vacuole (LCV). After a 4hour lag phase, L. pneumophila undergoes exponential growth within the LCV, with a
doubling growth rate of 60 minutes. By 16 to 18-hours post infection, the bacteria are
released into the host cell cytosol where another 1-2 rounds of replication occur [119122]. This is known as the post-exponential transmissive phase when the bacteria
become virulent, flagellated, and cytotoxic [112, 122, 123]. The final stage in the L.
pneumophila intracellular lifecycle is culminated by lysis of the host cell and the release
of the bacteria [124-126]. When a neighboring cell is infected, this cycle is repeated.
The successful intracellular lifestyle of Legionella within protozoa and macrophages is
only possible because of the export of bacterial protein effectors through the Type II
(T2SS) and Type IV (T4SS) secretion systems [127-129] .

The Type II Secretion System (T2SS)
The Type II secretion system (T2SS) exists in many Gram-negative bacteria,
including both plant and animal pathogens, but are mainly distributed among the genera
of Proteobacteria [130]. The T2SS is composed of 12 core proteins making up 4
subcomplexes (T2S C, D, E, F, G, H, I, J, K, L, M and O) [130]. The first subcomplex is
a multimer of T2S D proteins that provide the ultimate portal for transit across the outer
membrane (OM) and out of the cell known as “secretin”, second is an inner membrane
(IM) platform which provides a periplasm-spanning channel connection to the secretin,
comprised of T2S F, L and M [130]. The OM-associated subcomplex and the IM11

associated subcomplexes are coupled by the IM-associated “clamp protein” T2S C and
the third subcomplex is a periplasm-spanning pseudopilus, consisting of the major
pseudopilin T2S G and minor pseudopilins T2S H, I, J, and K, believed to act in a
“piston” or “screw-like” fashion [127, 130-133]. The fourth subcomplex is a hexamer of
T2S E, a cytoplasmic ATPase that is recruited to the IM to “power” the secretion process,
where T2S O protein is an IM-prepilin peptidase that cleaves and methylates the
pseudopilins as a prelude to their incorporation into the pseudopilus (Figure 1-1) [127,
130-133]. The T2S consists of a two-step process where proteins to be secreted are first
trafficked into the periplasm, folding into tertiary conformation, across the inner
membrane of the bacteria by the Sec translocon or the Tat pathway [131]. The second
step is responsible for secreting proteins that are recognized by the secretion apparatus to
the extracellular milieu via an outer membrane pore [131].
The L. pneumophila T2SS is important for intracellular infection of amoebae and
host cells, biofilm formation, planktonic survival, as well as growth in mouse models of
disease [134-138]. Nearly all pathogens that express the T2SS system exist within
aquatic and soil environments in addition to their higher organism hosts [131]. The T2SS
system functions at a temperature range of 22-37°C, temperatures commonly associated
with aquatic niches [136]. The intrapulmonary role of L. pneumophila’s T2SS involves
intracellular infection of macrophages by facilitating the onset of bacterial replication at 4
to 8 h post entry and the capacity to grow to large numbers at 12 h [138].
To date, the T2SS exports at least 27 proteins with 20 enzymatic activities, some
of which are responsible for degrading proteins and lipids [131, 139-142]. The effector
substrates of the T2SS system increase the likelihood of infection of amoebae with L.
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pneumophila. Secreted exoproteins have striking similarity to eukaryotic proteins. These
effectors include the acyltransferase PlaC, ribonuclease SrnA, metalloprotease ProA, and
two novel proteins – NttA and NttC [75, 133, 134, 143]. Each effector is important for
infection, and their importance varies depending on the species of amoebae. In addition
to amoebal infection, the secreted chitinase ChiA has been linked to bacterial persistence
in the lung [140]. Thus, the repertoire of L. pneumophila effectors secreted by the T2SS
system has evolved to enable adaptation to a broad host range [133].
Various studies have considered the importance of the T2SS system in relation to
its ability to survive in aquatic environments [106, 111-115]. One study from Söderberg
et al. has shown that T2SS mutants show a decreased ability to survive extracellularly at
a temperature range of 4-25°C, suggesting there are effectors secreted by the T2SS that
facilitate survival in low temperatures [136, 144]. It has also been shown that mutants
lacking the T2SS Lcl protein, an immunogenic GlycosAminoGlycans (GAG) binding
adhesion, are not able to form biofilms as efficiently as bacteria containing a functional
T2SS system [145, 146]. T2SS systems mutants have impaired gliding motility which is
likely the result of an inability to secret a novel surfactant, TolC [147-150]. T2SS
promotes infection of alveolar macrophages in the lungs by dampening the host cytokine
response and releasing damaging enzymes which could aid in prolonged bacterial growth
[135, 140, 151, 152]. The intracellular localization of many T2SS substrates is unknown,
however a recent study by Truchan et al. elucidated the cellular localization of ProA and
ChiA, which are secreted outside the LCV and then form a ring-like pattern around the
LCV membrane in the host cell cytosol [153, 154].
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The T2SS promotes the growth, ecology and virulence of L. pneumophila, with
mutants lacking the T2SS being severely impaired for infection of the natural hosts,
Acanthamoeba castellanii and Hartmannella vermiformis, indicating that proteins
secreted via T2SS are required for infection of protozoan hosts in addition to mammals
[133].

Figure 1-1 Architectural model of the T2SS.
Atomic models of T2SS components are superimposed on the central slice of the T2SS
Transmembrane domains of the IM proteins are shown as cylinders. Linkers between
N1E domain and N2E/CTE domains of T2S E are represented by dotted lines. OM =
outer membrane, IM = inner membrane, PG = peptidoglycan. Lipids are shown in dark
cyan and peptidoglycan dark yellow. Adapted from Figure 3: In vivo structure of the
Legionella type II secretion system by electron cryotomography[130].
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The Dot/Icm Type IV Secretion System (T4SS)
The Dot/Icm system is currently one of the most intensively studied T4SS
systems. The secretion system is an important virulence system involved in almost all
aspects of the intracellular biology of L. pneumophila, since bacteria lacking the secretion
system are not pathogenic and cannot replicate within host cells [155]. The T4SS is
specialized macromolecular delivery machines that are classified as T4ASS or T4BSS
[156]. The genes encoding the Dot/Icm system consists of a set of 27 genes that were
named dot (defective in organelle trafficking) or icm (intracellular multiplication) [157163]. The T4BSS of L. pneumophila is composed of 27 proteins that form a “Wi-Fi” like
structure, acting as a nano syringe and translocating approximately 350 effector proteins
from the bacterium’s cytoplasm across the LVC membrane into the host cell cytosol
(Figure 1-2) [164-172]
The T4BSS apparatus localizes to the pole of the LCV within macrophages and
polar secretion of substrates is crucial for the establishment of the LCV [173]. Two of the
Dot/Icm proteins, DotU and IcmF, target assembly of the T4SS apparatus to the cell poles
independently of other Dot/Icm proteins [156]. With the help of a secretion system
coupling complex comprised of DotL, DotM, and DotN, in association with three
chaperone proteins, IcmW, IcmS and LvgA, protein substrates in the bacterial cytoplasm
are delivered to the translocation channel in the inner membrane [164, 174-178]. The
DotC, DotD, DotF (IcmG), DotG (IcmE) and DotH (IcmK) proteins constitute a core
transmembrane complex, DotL (IcmO) is a type IV coupling protein that consists of a
conserved Nucleotide-Binding Domain (NBD) and an All α-helical Domain (AAD) [174,
179-181]. DotL appears to form a multiprotein type IV coupling protein complex with
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four other proteins, DotM (IcmP), DotN (IcmJ), IcmS and IcmW. The functions of these
four putative subunits are elusive, and how they interact with DotL remains unknown
[174, 179-181].
L. pneumophila injects >350 effectors, which constitutes the largest repertoire of
effector proteins translocated by bacterial pathogens into host cells, which accounts for
more than 11% of its genome coding capacity. The next closest is Coxiella burnetii,
which harbors ~100 putative effector proteins [182-186]. The translocated effectors have
a translocation signal, commonly found in the C-terminus that consists of a 20-35 amino
acid sequence that directs them to the T4SS and can include an E-Block motif
encompassing several glutamic acid residues [185, 187-190]. L. pneumophila also codes
for many metaeffectors, which are “effectors of effectors” that regulate the function of
other effectors injected within the host cell [191, 192]. Translocation of some effectors
appears to occur rapidly upon attachment of L. pneumophila to host cell plasma
membrane and phagocytosis of L. pneumophila, but not all effectors are simultaneously
translocated into the host cell at the onset of infection, resulting in a temporal control of
effector transcription and metaeffector activity [96, 187, 193, 194].
The T4SS is active in effector translocation for at least 8 hours after bacterial
uptake [195]. Expression and translocation of effectors is quite diverse. The SidM/DrrA
and SidE family of effectors can be detected early in infections but then disappear at later
stages [196-198], while LepB displays increased co-localization with the LCV during the
entire course of infection [196-198]. The temporal presence/control of some effectors
has been shown to be consistent with their biological function [196-198]. An example of
this is the set of effectors SidM, LepB and SidD that target Rab1 with antagonist
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activities to temporally control its activation/deactivation on the LCV early in infection
[197].
Metaeffectors regulate the function of other effectors through protein-protein
interactions. In addition to post-transcriptional regulation of effector levels in the host
cell by host proteasome or metaeffectors, effector activity is also achieved by control of
their secretion upon contact with the host cell [96, 191, 192, 199]. Proteomics have
shown control of effector synthesis impacting the timing of effector delivery. For
example, the replicative phase-effector MvcA (Lpg2148) is detected in the cell 5 hours
after injection of the transmissive phase effector MavC, allowing the deubiquitinase
activity of MvcA to reverse MavC-mediated UBE2N ubiquitination [199, 200].
Allombert et.al revealed that Dot/Icm secretion is controlled by c-di-GMP signaling, as
partial inactivation of c-di-GMP synthetizing diguanylate cyclase Lpl0780/Lpp0809, or
partial overproduction of c-di-GMP degradation enzymes, results in significant changes
in the rate and timing of some effector translocation [201].
The single deletion of effector proteins of L. pneumophila often does not result in
an intracellular growth defect in macrophages due to functional redundancy of many
effectors of L. pneumophila [202-206]. Even deletion of up to 31% of the effectors causes
only marginal replication defects in mouse macrophages [205]. Functional redundancy
may occur via different mechanisms including pathway redundancy, cellular process
redundancy, target redundancy, molecular redundancy, and system redundancy [204].
Redundant effector proteins have been shown to perform the same function in host cells
and interact with the same host cell targets. One well characterized example of this is the
SidE family of effectors [202]. The SidE family consists of four effector proteins (SidE,
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SdeA, B, and C) which function to catalyze the addition of ubiquitin moieties to the host
proteins Reticulon 4 and Rab33b [207, 208]. When each of these effectors are
individually deleted, there is no replication defect detected in macrophages, but when all
four effector proteins are deleted, there is a significant decrease in intracellular
replication of L. pneumophila, which can be restored with complementation of SdeA
alone [208, 209].
Very few effector proteins have been shown to be vital for intracellular replication
in macrophage infection by L. pneumophila, a likely result of functional redundancy
among effector proteins as lack of a mammalian host target to the effector [202, 204,
205]. It is likely that over time L. pneumophila has accumulated a toolbox of effector
proteins as a result of horizontal gene transfer during adaptation to many protozoan
species. Different effectors are likely specific for infection of specific protozoan hosts.
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.
Figure 1-2 Schematic of the periplasmic portion of the Legionella Dot/Icm type IV
secretion system.
Components whose structures are not known or are confidently predictable are depicted
as circles (e.g., DotC) or as the shape of densities seen in the subtomogram averages or
difference maps (e.g., DotH and IcmX). Polypeptide links to the outer membrane are
shown as dotted lines. The sequences in DotG with unknown structure are shown as
solid lines with a speculative path. A large number of transmembrane helices are not
shown for inner membrane proteins (DotA, DotE, DotL, DotM, DotP, DotU, DotV, IcmV
and IcmT). In addition, cytoplasmic components of the system are not shown. Lipids are
shown in grey (OM is outer membrane and IM is inner membrane) and peptidoglycan in
brown (PG). DotA is the T4SS mutant used in this study as a negative control (circled in
red). Adapted from Figure 4: Molecular architecture of the Legionella Dot/Icm type IV
secretion system [210].
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Core Effectors of L. pneumophila
The vast number of effectors in the toolbox of L. pneumophilia likely allows for
its ability to infect a wide range of hosts as a “generalist” pathogen, while most pathogens
tend to be specialized and are restricted to one host. Legionella spp. harbor more than
18,000 unique translocated effectors [211]. A large number of the effectors contain
eukaryotic-like domains and motifs acquired from all domains of life [211]. Remarkably,
only eight core effectors are conserved in all 58 analyzed Legionella genomes [183, 211].
These core effectors of Legionella are MavN, VipF, RavC, CetLp1, lpg2832, lpg3000,
lpg1356/lpp1310, and AnkH/LegA3/Lpg2300 [183, 211]. One effector, MavN, has
orthologs in all the sequenced Legionella as well as one other bacterium encoding the
Dot/Icm T4SS, Rickettsiella grylli [137]. MavN a protein associated with the LCV
membrane and required for efficient iron acquisition during intracellular growth,
allowing microbial bypass of host iron restriction [212, 213]. AnkH/LegA3/Lpg2300,
targets the host LARP7 component of the 7SK snRNP complex which interferes with
host transcriptional elongation cite. The AnkH effector was the only core effector
conserved across the Legionella genus and also present in other organisms containing the
Dot/Icm T4SS such as Coxiella burnetii and Rickettsiella grylli [183, 211].

Evolution and Phylogeny of Legionellae
Plasticity is a qualitative trait of an organism providing a possible fitness
advantage in response to different hosts [214]. The plasticity of the L. pneumophila
genome is likely impacted by its co-evolution with numerous protozoan hosts. L.
pneumophila is competent of natural transformation of DNA and is capable of
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conjugation by the T4ASS [163, 215, 216]. Co-evolution and adaption of L.
pneumophila to numerous protozoan hosts and inter-kingdom Horizontal Gene Transfer
(HGT) may explain the genome plasticity, the large repertoire of effector proteins and
their effector redundancy, and presence of effectors containing eukaryotic-like domains
and motifs [217-219].
Pathogenic evolution and intracellular adaptation of L. pneumophila to a broad
range of protozoan hosts has been shaped largely by intra-species, inter-species and interkingdom HGT, as well as intra-species recombination events [206, 211, 220-224]. In
addition, some HGT of L. pneumophila has likely come from protozoan endosymbionts
and intra-protozoan bacteria [217-219]. It may not be surprising that recent phylogenetic
studies have indicated that the Dot/Icm translocation system and two of its translocated
core effectors (AnkH and MavN) [224], present in all Legionella species as well as
Coxiella and Rickettssia, have been acquired by the bacterium during very early events of
its evolution and protozoan host adaptation [225]. It is thought that the key events in host
adaptation events in L. pneumophila have taken place very early in its evolution of the
last Legionella common ancestors (LLCA) in the deep-branching gammaproteobacterial
order Legionellales, which contains among others Coxiella, Rickettssia, and Legionella
[225]. It is estimated that LLCA diverged approximately 1.89 billion years ago. This
implies that the protozoan hosts adaptation events in Legionellales have occurred
between 2.12 and 1.75 Ga [225]. Early evolution of Legionella-protozoan host
interaction has played a major role in subsequent transmission and pathogenesis of L.
pneumophila to the accidental human host.
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Effectors Involved in Vacuolar Biogenesis
Phagocytosis is a form of endocytosis that refers to cellular uptake of large
particles and is initiated by the interaction of surface receptors with their cognate ligand
[226, 227]. Upon phagocytosis, the nascent phagosome undergoes a complex sequence
of maturation events governed by regulators of the endosomal-lysosomal degradation
pathway that yields an acidic degradative compartment designated as the phagolysosome
[226, 228]. Phagocytic cells are equipped with a variety of receptors that recognize
foreign material and particles permitting them to internalize the particles into a plasmamembrane derived vacuole that follows a maturation process that ultimately yields a
phagolysosome [226]. Additionally, non-immune cells are equipped with receptors
utilized by bacterial pathogens such as Chlamydia to enter by receptor-mediated
endocytosis [229]. Therefore, successful evolution of intra-vacuolar pathogens is
dependent on their capacity to evade innate immune pathways and modulate biogenesis
of their vacuole and adaptation to the unique micro-environment within the vacuole
[230]. Depending on the phagocytosed bacterial pathogen, the default maturation of the
phagosome along the endosomal-lysosomal pathway is overridden by specific pathogenproduced factors that interfere with the fate of the pathogen-containing vacuole [231].
All intra-vacuolar pathogens possess specialized secretion systems (T3SS-T7SS) that
inject effector proteins into the host cell cytosol to modulate a variety of host cell
processes and remodel their vacuoles into proliferative niches [232]. Although
intravacuolar pathogens utilize similar secretion systems to interfere with their vacuole
biogenesis, each pathogen has evolved a unique toolbox of protein effectors injected into
the host cell to interact with, and modulate, biogenesis of the vacuole. The interference
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and divergence of the pathogen-containing vacuole from the default endosomallysosomal pathway is at the crux of the successful evolution to the intra-vacuolar
microenvironment and inflict pathology and disease [233-235]. Despite being an
accidental human pathogen, Legionella utilize the same lysosomal evasion mechanisms
to avoid killing by its natural amoeba hosts and human macrophages [232, 236, 237].
Within alveolar macrophages and the amoeba hosts, the LCV evades fusion with
vesicles of the endosome-lysosomal pathway [117] and intercepts ER-to-Golgi vesicle
traffic regulated by Rab1A/Rab1B [238, 239], Rab2 [240], at least one SNARE complex
composed of one v-SNARE (Sec22b), and three cognate t-SNAREs (syntaxin 5,
membrin, and Bet1) (Figure 1-3) [241, 242]. Both Rab1 and Arf1 have been found to be
localized to the LCV by 30 min post infection [243-245]. In addition, Sar1 and Arf1, two
small GTPases, regulate the formation of COPII and COPI-coated vesicles and are
required for the production of early secretory vesicles [246-248]. The expression of
dominant interfering mutants in the three small GTPases (Sar1, Rab1, and Arf1) inhibits
biogenesis of the LCV and decreases intracellular survival of L. pneumophila [244, 245,
249].
The function of most Dot/Icm-injected effectors is still to be determined.
However, few effectors have shown to be involved in LCV biogenesis. The RalF effector
functions as a GEF to recruit the ADP-ribosylation factor 1 (Arf1) to the LCV [243].
This enables the GEF-like RalF effector to modulate membrane transport in the secretory
pathway [250]. Additionally, the DrrA/SidM effector preferentially recruits Rab1 and
tethers ER-derived vesicles to the LCV, mediated by another L. pneumophila effector,
LidA [166]. DrrA/SidM may compete with endogenous guanine nucleotide exchange
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factors (GEFs) to redirect Rab1 from its normal secretory intracellular localization to
plasma membrane-derived vesicles [251]. The LepB effector accumulates on the LCV as
DrrA/SidM and Rab1 cycle off and has been shown to function as a GTPase activating
protein (GAP) for Rab1 (Figure 1-3) [196, 252]. While LidA binds several Rab GTPases
including Rab1, it may sequester Rab proteins or tether ER-derived vesicles with the
LCV to facilitate SNARE-mediated fusion [252]. The VipD effector belongs to a family
of bacterial effectors that contain the N-terminal lipase domain and a C-terminal domain
[253]. VipD localizes to early endosomes via the C-terminal domain and interferes with
endosomal trafficking through blocking interaction of Rab5 and Rab22 with EEA1 [253].
VipD binds to the endosomal regulator Rab5 and triggers the hydrolytic phospholipase
A1 activity of VipD, causing the removal of the lipid phosphatidylinositol 3-phosphate
facilitating endosomal lysosomal evasion by L. pneumophilia [254]. The SidE family of
effector proteins (SidE, SdeA, SdeB, and SdeC) have been found to catalyze the noncanonical ubiquitination of Rab small GTPases, leading to a potential role in vesicular
trafficking [255].
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②

①

Figure 1-3 Model for the regulation of Rab1 activity by Legionella proteins.
(A) SidM associated with the LCV membrane extracts Rab1 from the Rab1-GDI complex
and subsequently activates Rab1 by its GEF and AMPylation activity. AMPylated Rab1
becomes inaccessible to GAP proteins such as LepB and TBC1D20, thereby is locked
into its active state. (B) The deAMPylase SidD removes the AMP moiety from Rab1,
making it accessible to LepB, which stimulates its GTPase activity, leading to the
extraction of the inactive Rab1 from the bacterial phagosome by an unknown GDI. The
time frame for each event occurring during infection is indicated as ①: First 2 hours of
infection. ②: After 2 hours of infection. The LCV is formed by type IV-secreted
effector proteins that bind to PI lipids (PtdIns (3)P or PtdIns (4)P), recruit PI-modifying
host enzymes (PI4KIIIβ or OCRL1) or modify small GTPases (Rab1 or Arf1). L.
pneumophila effectors show activity as GEF (SidM and RalF), GAP (LepB), AMPylase
(SidM), de-AMPylase (SidD), LidA binds to activated Rab1 and other GTPases. GDI,
GDP dissociation inhibitor. Adapted from Figure 3: Secretive Bacterial Pathogens and
the Secretory Pathway[256] and Figure 1: Take it and release it: The use of the Rab1
small GTPase at a bacterium's will [257]
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SPECIFIC AIMS
Manifestation of Legionnaires’ disease is totally dependent on the intracellular
proliferation of L. pneumophila in alveolar macrophages within the Legionella-containing
vacuole (LCV), which is trafficked through a unique pathway controlled by the pathogen.
The LCV intercepts endoplasmic reticulum (ER)-derived vesicles and evades lysosomal
fusion [116, 258]. Biogenesis of the LCV and subsequent proliferation of L.
pneumophila within the LCV is dependent on the Dot/Icm type IV translocation system
[117, 244], which directly translocates ~350 effector proteins from the bacterial
cytoplasm into the host cell [190, 259-262]. Although many Dot/Icm-translocated
effectors have been shown to directly regulate the early secretory system of the host cell,
with the exception of VipD, no L. pneumophila effector has ever been shown to be
indispensable for evasion of the endosomal-lysosomal degradation pathway, which
continues to be a major gap in our knowledge of evasion of degradation of L.
pneumophila by macrophages [190, 263-265]. Importantly, evasion of the endosomallysosomal degradation pathway by intracellular bacterial pathogens in general is not well
understood. However, the effector VipD localizes to early endosomes and interferes with
endosomal trafficking by blocking interaction of Rab5 and Rab22 with EEA1. VipD
binds the endosomal regulator Rab5 subsequently causing the removal of the lipid
phosphatidylinositol 3-phosphate, facilitating endosomal lysosomal evasion by L.
pneumophilia [253, 254].
A gene fusion strategy has allowed the identification of carboxyl terminal
translocation signals of previously unidentified effector proteins in Legionella [190].
The effectors were identified as either Rav (Regions Allowing Vacuole colocalization) or
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Mav (More regions Allowing Vacuole colocalization) [190]. This study revealed the
translocated effector protein MavE (lpg2344). MavE contains a C-terminal
transmembrane domain but lacks the E-block motif needed for injection of many Dot/Icm
translocated substrates [190]. A Basic Local Alignment Search Tool (BLAST) search
revealed MavE is widely conserved throughout the Legionella genus. Through highthroughput screening in yeast, a direct interaction of MavE and the effector YlfA/LegC7
was discovered [191]. YlfA/LegC7, along with two other effectors (LegC2 & LegC3),
assembles in a complex on the LCV and interact with ER-derived vesicles to initiate
membrane fusion [190, 191, 266-268]. However, whether the LegC7/LegC2/LegC3
complex interacts with MavE is not known. In addition, the subcellular localization of
MavE during infection is not known and determining the role of MavE during infection
will further explain LCV biogenesis and lysosomal evasion of L. pneumophila.
The structure of MavE harbors with a eukaryotic NPxY motif involved in binding
to phosphotyrosine-binding (PTB) adaptor proteins involved in fusion of early secretory
vesicles [269]. Here I show an essential role for MavE in intracellular proliferation of L.
pneumophila within hMDMs and amoeba. Our central hypothesis is L. pneumophila
utilizes the MavE effector to bypass the endosomal-lysosomal degradation pathway. To
test the hypothesis, our specific aims are:
Specific Aim 1: Temporal role for MavE in bypassing lysosomal degradation by L.
pneumophila
Specific Aim 2: The role of the NPxY motif of MavE in lysosomal evasion
Specific Aim 3: Identification of MavE-interacting proteins on the LCV Membrane
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When these studies are completed, we expect the following response of hMDMs
to L. pneumophila. We know MavE is translocated by the T4SS and suspect the NPxY
motif to interact with host adaptor proteins involved in endosomal-lysosomal fusion,
facilitating lysosomal evasion by the LCV (Figure 1-4).

Figure 1-4: A working model of the response of hMDMs to L. pneumophila
infection. A working model for the role of MavE in lysosomal evasion by the LCV.
MavE is translocated by the T4SS and the NPxY motif of MavE interacts with host
adaptor proteins involved in endosomal-lysosomal fusion. The LegC2, 3, 7 complex
interacts with MavE.
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CHAPTER 2:
AN INDESPENSIBLE ROLE FOR THE MavE EFFECTOR OF LEGIONELLA
PNEUMOPHILA IN LYSOSOMAL EVASION*

___________________
* Vaughn B, Voth K, Price CT, Jones S, Ozanic M, Santic M, Cygler M, Abu Kwaik Y.
An Indispensable Role for the MavE Effector of Legionella pneumophila in Lysosomal
Evasion. mBio. 2021 Feb 9;12(1): e03458-20. doi: 10.1128/mBio.03458-20.
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Summary
Diversion of the Legionella pneumophila-containing vacuole (LCV) from the host
endosomal-lysosomal degradation pathway is one of its main virulence features essential
for manifestation of Legionnaires’ pneumonia.

Many of the ~350 Dot/Icm-injected

effectors identified in L. pneumophila have been shown to interfere with various host
pathways and processes; but no L. pneumophila effector has ever been identified to be
indispensable for lysosomal evasion.

While most single effector mutants of L.

pneumophila do not exhibit a defective phenotype within macrophages, we show that the
MavE effector is essential for intracellular growth of L. pneumophilia in human monocytederived macrophages (hMDMs), amoebae and for intrapulmonary proliferation in mice.
The mavE null mutant fails to remodel the LCV with ER-derived vesicles and is trafficked
to the lysosomes where it is degraded, similar to formalin-killed bacteria. During infection
of hMDMs, the MavE effector localizes to the poles of the LCV membrane. The crystal
structure of MavE resolved to 1.8 Å, reveals a C-terminal transmembrane helix, three
copies of tyrosine-based sorting motifs, and an NPxY eukaryotic motif, which binds
phosphotyrosine binding domains present on signaling and adaptor eukaryotic proteins.
Two-point mutations within the NPxY motif results in attenuation of L. pneumophila in
both hMDMs and amoeba, and the substitution defects of P 78 and D64 are associated with
failure of vacuoles harboring the mutant to be remodeled by the ER and in fusion of the
vacuole to the lysosomes leading to bacterial degradation. Therefore, the MavE effector
of L. pneumophila is indispensable for phagosome biogenesis and lysosomal evasion.
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Importance
Intracellular proliferation of Legionella pneumophila within a vacuole in human
alveolar macrophages is essential for manifestation of Legionnaires’ pneumonia. Intravacuolar growth of the pathogen is totally dependent on remodeling the L. pneumophilacontaining vacuole (LCV) by the ER and on its evasion of the endosomal-lysosomal
degradation pathway. The pathogen has evolved to inject ~350 protein effectors into the
host cell where they modulate various host processes; but no L. pneumophila effector has
ever been identified to be indispensable for lysosomal evasion. We show that the MavE
effector localizes to the poles of the LCV membrane and is essential for lysosomal evasion
and intracellular growth of L. pneumophilia and for intrapulmonary proliferation in mice.
The crystal structure of MavE show an NPxY eukaryotic motif essential for ER-mediated
remodeling and lysosomal evasion by the LCV. Therefore, the MavE effector of L.
pneumophila is indispensable for phagosome biogenesis and lysosomal evasion.
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Introduction
Intracellular pathogens that reside in vacuoles within macrophages have evolved
with mechanisms to evade the endosomal lysosomal degradation [235, 270] and autophagy
pathways [271] as well as other innate defense pathways [272, 273]. Cytosolic pathogens
have also evolved with mechanisms to cytosolic detection by the innate defense processes
of macrophages [274].
Legionella pneumophila is a Gram-negative environmental bacterium, naturally
infecting amoebae in water sources [206]. The bacterium evades lysosomal degradation
by amoebae and proliferates intracellularly [206]. L. pneumophila can become aerosolized
allowing for environmental transmission to human hosts. Once inhaled into the lungs, L.
pneumophila infects resident alveolar macrophages, causing a severe pneumonia known as
Legionnaires’ disease [10, 275, 276]. Within macrophages, L. pneumophila grows in a
membrane-bound vesicle known as the Legionella containing vacuole (LCV) [203, 259].
The LCV fuses with endoplasmic reticulum (ER)- derived vesicles and evades lysosomal
fusion [116]. Proliferation of L. pneumophila within the LCV is dependent on the Dot/Icm
type IV secretion system (T4SS) [117, 244], which translocates ~350 effector proteins into
the host cell [190, 259-262]. These injected effectors have evolved to manipulate various
host cell processes in order to remodel the host cell into a proliferative niche for pathogen
proliferation [118, 203]. The loss of function of this secretion system causes defective
phagosome biogenesis in terms of recruitment of ER-derived vesicles to the LCV and in
rapid fusion to of the LCV to the lysosomes [117, 203, 277].
The ability of the LCV to be remodeled into an ER-derived vacuole and evade
degradation through the endosomal-lysosomal pathway is a key virulence determinant of
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L. pneumophila [203, 207, 278]. However, the mechanism L. pneumophilia employs to
evade lysosomal fusion is still unclear, but it is regulated at various levels [279]. Multiple
Dot/Icm translocated effectors directly regulate vesicular traffic associated with the early
secretory system [190, 263-265]. Few of the T4SS effector proteins, such as DrrA/SidM,
LidA, VipD, and LepB have been shown to be partially required for lysosomal evasion
[264, 280, 281]. Many of these effectors interact with small host GTPases and/or Rab
proteins, which are prominent targets of L. pneumophila effector proteins [282-285].
However, to date, no known effector has proven to be indispensable for evasion of the
endosomal-lysosomal degradation pathway. The prevalence of functional redundancy
among the 350 L. pneumophila effectors suggests key host pathways are targeted by L.
pneumophilia [286], and many of these pathways are highly conserved through evolution
from unicellular eukaryotes, such as amoeba, to mammals [287, 288]. Redundancy of
effectors occurs in many different manners, including molecular mimicry, targets,
pathways, cellular processes, and system redundancy [204]. However, the redundancy of
effectors likely represents a toolbox for L. pneumophila to replicate within diverse
environmental hosts; having specific effectors for certain hosts and some of the amoebaeadapted effectors may have unpredicted paradoxical effects on human macrophages [202206].
The MavE (Lpg2344) effector was first identified in a screen aimed at identification
of new translocated substrates based on the presence of glutamate-rich motif found in more
than half of L. pneumophila effectors [190]. While the amino acid sequence of MavE has
no homology to known proteins, a BLAST search revealed MavE is widely distributed
throughout the Legionella genus, but its role in the infection remains unknown [289, 290].
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Recently, a yeast two-hybrid screen revealed that MavE has a direct interaction with
another effector protein, a metaeffector, YlfA/LegC7 [190, 191]. YlfA/LegC7 modulates
ER vesicle trafficking events [267].

YlfA/LegC7 along with two other effectors,

YlfB/LegC2 and LegC3 assemble as a complex on the LCV that interacts with ER-derived
vesicles to initiate membrane fusion [266-268]. Single ylfA and ylfB mutants and an ylfAylfB double mutant replicate similar to the WT strain in macrophages [291]. However, in
single cell assays, the YlfA-YlfB double mutant exhibits ~30% reduction in ER-mediated
remodeling and formation of replicative LCVs [292]. However, the ylfA-ylfB double
mutant is similar to the WT strain in lysosomal evasion, indicating that ER-mediated
remodeling and lysosomal evasion of the LCV are two independent events [292].
However, the role of this LegC7/LegC2/LegC3 complex in association with MavE in
intracellular proliferation and lysosomal evasion by L. pneumophila is not known.
The combination of the eukaryotic motifs in MavE and metaeffector activity of
YlfA/LegC7 suggests the MavE effector is likely involved in governing biogenesis of the
nascent LCV [190]. Here we demonstrate that the MavE effector is the first effector
identified to be indispensable for diverting the LCV from the endosomal-lysosomal
pathway and is essential for intracellular replication in human macrophages, amoebae, as
well as for intrapulmonary proliferation in mice. MavE is localized to the LCV pole, which
is consistent with localization of the Dot/Icm translocation apparatus. The crystal structure
of MavE shows a single-pass transmembrane domain at its C-terminus, an NPxY
eukaryotic motif, and three copies of the tyrosine-based sorting motifs [293-295]. Our data
show the NPxY eukaryotic motif, and the P and the upstream D residue of MavE are
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required its function in ER-mediated remodeling of the LCV and lysosomal evasion, both
of which are essential for intracellular proliferation.

Results
Subcellular Localization of MavE
Since pathogenic effectors injected into host cells have distinct sub-cellular
localization where they interact with specific targets, the sub-cellular localization of MavE
during infection was determined by transiently transfecting HEK293T cells with a
construct encoding 3X-FLAG tagged MavE to enhance expression and detection of MavE.
Following 24h, the cells were infected with wild type L. pneumophila, a translocationdeficient (ΔT4SS) dotA mutant, or the mavE mutant for 2h. Ectopic expression of MavE
exhibited distinct punctate distribution throughout the cell, indicative of vesicular
localization (Figure 2-1A). Remarkably, 3X-FLAG tagged MavE was trafficked to 90%
of wild type strain-containing LCVs and this co-localization is Dot/Icm-dependent since
the ΔT4SS mutant vacuoles exhibited less than 5% co-localization. In cells infected with
the mavE mutant, MavE was trafficked to 10% of LCVs only. These data suggest that
other Dot/Icm-injected effectors may be required during infection, and injection of various
effectors is required for proper localization of MavE to the LCV membrane.
To examine sub-cellular localization of MavE during infection of macrophages, we
constructed L. pneumophila strains that express 4HA-tagged MavE fusions and infected
human monocyte-derived macrophages (hMDMs) for 1hr. Following fixation, the plasma
membranes of infected hMDMs were differentially permeabilized using digitonin to detect
if MavE was exposed to the cytosol. The 4HA-MavE translocated by wild type bacteria
was spatially and exclusively localized to the cytosolic side of 80% of the LCVs (Figure
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2-1B). Interestingly, MavE was concentrated at the LCV poles, which is consistent with
the localization of the Dot/Icm translocation system to the bacterial poles [296]. MavE
was not detected on LCVs harboring the ΔT4SS mutant (Figure 2-1B). To exclude
potential effect of digitonin on co-localization to the LCV, methanol fixation was utilized
after the infection but digitonin was excluded. The data showed that the 4HA-tagged MavE
was consistently concentrated at the LCV poles in WT infected hMDMs in a Dot/Icmdependent manner (Figure 2-2).
The detection of MavE on wild type strain-containing LCVs decreased rapidly and
significantly over time, with only 30% of LCVs decorated with MavE at 3h post-infection.
As the HA tagged MavE used was IPTG-inducible, the MavE was synthesized by the
bacteria prior to infection. To determine if the loss of MavE was due to host proteasomal
degradation, MG132 was used to inhibit the proteasomes [297].

We have shown

previously that inhibition of proteasomal degradation blocks replication of L. pneumophila
within hMDMs due to the lack of sufficient amino acids but has no detectable effect on
phagosome trafficking and is totally reversible upon supplementation of amino acids [297].
The data showed that upon inhibition of the proteasomes, MavE was retained on the LCVs,
suggesting that MavE is degraded by the host proteasomes (Figure 2-1C).
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Figure 2-1: Localization of MavE during ectopic expression and during infection of
hMDMs. (A) Representative confocal microscopy images of transfected HEK293T cells
with 3X-FLAG tagged MavE. Cells were infected for 2hrs, in triplicate, using wild type
L. pneumophila, the ∆T4SS mutant, or the mavE mutant (green). Ectopic expression of
MavE exhibited distinct punctate distribution throughout the cell (red). Quantification of
co-localization of MavE with the LCV (indicated by arrowheads-yellow) is shown in
merged images. (B) Representative confocal microscopy images of 4HA-tagged MavE
(red) constructs in both wild type and T4SS L. pneumophila (green), following 1hr
infection in hMDMs. Quantification of co-localization of MavE with the LCV (indicated
by arrowheads-yellow) is shown in merged images. ND indicates not detectable. (C)
The presence of MavE on wild type LCVs decreased from 1hr-3hr post infection. The
proteasome inhibitor, MG132, blocked the loss of MavE (Student t-test, *p ≤ 0.05; ** p ≤
0.01; *** p ≤ 0.001, ns indicates not significant)
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Figure 2-2: Localization of MavE during infection of hMDMs without digitonin
treatment. (A) Representative confocal microscopy images of 4HA-tagged MavE (red)
constructs in both wild type and ΔT4SS mutant of L. pneumophila (green), following 1hr
infection in hMDMs followed by methanol fixation without digitonin treatment. ND
indicates, not detected. Quantification of co-localization with the LCV (indicated by
arrowheads-yellow) is shown in merged images. Infected monolayers were fixed in 20 ̊C methanol for 5 mins. The results are representative of three independent
experiments performed in triplicate. A total of 100 infected cells for each replicate were
counted for presence or absence of localization.
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The role of MavE in intracellular replication
With few exceptions, most single effector mutants in L. pneumophila do not exhibit
a defective phenotype in macrophages [206]. To further examine the function of MavE,
we determined if MavE was required for intracellular replication. An isogenic mutant was
generated and used to infect hMDMs. Growth of the mavE mutant during in vitro broth
culture was identical to the wild type strain (Figure 2-3A). The data showed that the mavE
mutant failed to replicate in hMDMs, similar to the translocation-deficient T4SS mutant
(Figure 2-4A). Complementation of the mavE mutant (mavE/C) reversed the severe
intracellular growth defect. Infection of Acanthamoeba polyphaga, a natural host of L.
pneumophila, exhibited ~10-fold less mavE mutant bacteria recovered at 24 and 48hr postinfection compared to those infected with the wild type or the complemented mutant
(mavE/C) (Figure 2-4B).

39

Figure 2-3: Growth of substitution mutants in vitro and expression and stability of
the variant MavE proteins. (A) Overnight cultures of WT and ΔmavE, in BYE broth
were grown overnight at 37°C then diluted to OD550 0.05 and grown at 37°C for 24h.
Growth rates were determined by measuring optical density at 550nm every two hours,
for 12, then again at 24h post-inoculation. Data is representative of three independent
experiments. (B) Overnight cultures of WT, ΔmavE, and NPxY substitution mutants in
BYE broth were grown overnight at 37°C then diluted to OD 550 0.05 and grown at 37°C
for 24h. Growth rates were determined by measuring optical density at 550nm every two
hours, for 12, then again at 24h post-inoculation. Data is representative of three
independent experiments. (C) Immunoblots of total bacterial lysates from WT L.
pneumophila and each of the MavE substitution attenuated mutant strains. Cell lysates of
equivalent number of bacteria were subjected to immunoblotting using rabbit anti-MavE
antiserum [298, 299].
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Figure 2-4: MavE is essential for intracellular replication in hMDMs and A.
polyphaga. (A) To determine intracellular replication of the WT strain, the T4SS mutant,
the mavE mutant, and complemented mavE mutant (mavE/C), hMDMs were infected and
number of CFUs was determined at 2 and 24 h post-infection. Data points represent
(mean CFUs ± SD, n = 3) and are representative of three independent experiments. (B)
To determine intracellular replication of the WT strain, the T4SS mutant, the mavE
mutant, and complemented mavE mutant (mavE/C), A. polyphaga were infected and the
number of CFUs was determined at 2, 24 and 48 h post-infection. Data points represent
(mean CFUs ± SD, n = 3) and are representative of three independent experiments.
(Student t-test, * p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001)
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In the A/J mouse lethality model, using an intratracheal inoculation of 10 7 cfu
(LD50), the mavE mutant was completely attenuated, with 100% animal survival at 10days post-infection (Figure 2-5A). In contrast, both WT and the complemented mavE
mutant showed 50% lethality (Figure 2-5A). To determine if the mavE mutant has a defect
in intrapulmonary growth, A/J mice were intratracheally infected with 10 6 cfu to determine
intrapulmonary proliferation. At 2, 6, 12, 24, 48 and 72 hours, the bacterial burden was
determined in the lungs, spleen, and liver. Compared to the WT bacterial burden, a
decrease of bacterial burden of the mavE mutant was observed in lung tissue at 72 hours
post infection (Figure 2-5B). Following 24 hours post infection, a decrease in bacterial
burden was found in both the spleen and liver for the mavE mutant bacterial strain (Figures
2-5C & D). The A/J mice intratracheally infected with the complemented mavE mutant
was similar to infection by WT bacteria in bacterial burden in the lungs, spleen and liver.
Taken together, the MavE effector is essential for intracellular growth in macrophages,
amoeba, and contributes to intrapulmonary proliferation in mice.
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Figure 2-5: The MavE effector is essential for intrapulmonary replication in vivo.
(A) Mouse lethality assay in which A/J mice were intratracheally infected with wild type,
the mavE mutant, and complemented strains (mavE/C) at 107 CFU and monitored for 10
days. (B) Lung CFUs were determined in A/J mice at 2, 6, 12-, 24-, 48- and 72-hours
post inoculation. The CFUs in the mavE mutant intratracheally infected mice compared
to both the wild type and complemented strains (mavE/C) are shown. (C) Spleen CFUs
were determined of wild type, mavE mutant and complemented strain (mavE/C)
determined in intratracheally infected A/J mice at 2, 6, 12-, 24-, 48- and 72-hours post
inoculation. (D) Liver CFUs were determined in intratracheally infected A/J mice at 2, 6,
12-, 24-, 48- and 72-hours post inoculation for the wild type, mavE mutant and
complemented strain (mavE/C). (Student t-test, *p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001,
n=18)
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Role of MavE in ER-mediated remodeling and lysosomal evasion by the LCV
Since the mavE mutant is defective for intracellular growth, we determined if
trafficking of the vacuole harboring the mutant was altered. To determine if the mavE
mutant failed to create an ER- derived vacuole, we utilized confocal microscopy to
determine co-localization of the LCV with the ER marker, KDEL. The data showed that
over 90% of LCVs harboring wild type bacteria co-localized with KDEL, while only 15%
and 8% of the mavE mutant and formalin killed WT (FK-WT)-containing vacuoles,
respectively, co-localized with the ER marker (Figure 2-6A). Much like WT-containing
LCVs, 87% of the complemented mutant (mavE/C) containing LCVs co-localized with
KDEL.
To examine co-localization with late endosomes/lysosomes, the late endosome/
lysosomal marker, LAMP1, was utilized. Our data showed that only 5% of the wild type
containing LCVs co-localized with the LAMP1 marker. In contrast, 88% of LCVs
harboring the mavE mutant co-localized with LAMP1 (Figure 2-6B). The defect of the
mutant was restored upon complementation where only 15% of the vacuoles harboring the
complemented mavE mutant co-localized with LAMP1.

For the LCVs containing FK-

WT bacteria as a control, ~90% of the vacuoles co-localized with the LAMP1 marker.
Importantly, 70% of LCVs harboring the mavE mutant co-localized with the
lysosomal marker, Cathepsin D, similar to formalin-killed bacteria, while only 9% of LCVs
harboring the wild type strain localized with Cathepsin D (Figure 2-6C). Importantly, in
contrast to the bacilli shape of WT bacteria, the majority of the mavE mutant bacteria
exhibited altered morphology that included rounding and blebbing, indicative of bacterial
degradation, which is consistent with fusion of the LCV to the lysosome (Figure 2-7).
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Taken together, MavE is the first effector of L. pneumophila shown to be indispensable for
biogenesis of the LCV and lysosomal evasion.

Figure 2-6: Fusion of the vacuoles containing the mavE mutant with the lysosome
(A) Co-localization of the LCVs containing wild type, formalin-killed (FK) L.
pneumophila, mavE mutant, or the complemented strain (mavE/C) labeled with the ER
marker, KDEL (green), DAPI (blue) and anti-Legionella (red). Quantification of colocalization with the LCV (indicated by arrowheads-yellow) is shown in merged images.
(B) Co-localization of the LCVs containing wild type, formalin-killed (FK) L.
pneumophila, mavE mutant, or the complemented strain (mavE/C) stained with the late
endosome/early lysosomal marker, LAMP1 (green), DAPI (blue) and anti-Legionella
(red). Quantification of co-localization with the LCV (indicated by arrowheads-yellow)
is shown in merged images. (C) Co-localization of the LCVs containing wild type,
formalin-killed L. pneumophila, mavE mutant, or the complemented strain(mavE/C)
stained with the lysosomal marker, Cathepsin D (green), DAPI (blue) and anti-Legionella
(red). Quantification of co-localization with the LCV (indicated by arrowheads-yellow)
is shown in merged images. All analyses were performed on 100 infected cells analyzed
from multiple cover slips. The results are representative of three independent
experiments performed in triplicate.
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Figure 2-7: An essential role for MavE in bacterial viability within the LCVs of
hMDMs (A) Representative confocal microscopy images of wild type, formalin killedwild type, mavE mutant and the translocation deficient T4SS mutant L. pneumophila,
following 1hr infection in hMDMs. The cells were fixed and stained with anti-Legionella
(green) and DAPI (blue). All analyses were performed on 100 infected cells analyzed
from multiple cover slips. The results are representative of three independent
experiments performed in triplicate, and error bars represent standard deviation. (Student
t-test, *p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001)
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Crystal Structure of MavE
MavE contains a predicted transmembrane helix at the C-terminus (aa 183-206).
This region was excluded from the constructs submitted to crystallization to assure protein
solubility. We succeeded in crystallizing construct MavE (39-172). Its crystal structure
was solved by single anomalous dispersion (SAD) and refined to a resolution of 1.8 Å.
There are three molecules in the asymmetric unit, designated A, B and C. Molecules B and
C are related by twofold symmetry, and molecule A is also related by a twofold axis to a B
chain in a neighboring unit cell (Figure 2-8A). This organization results in two layers of B
and C molecules being sandwiched between a single layer of A molecules (Figure 2-8A).
MavE (39-172) is comprised of five α-helices, which are designated from N- to C-terminus
as A, B, C, D, and E. The N- and C-terminal residues of MavE are near one another, with
helices A and E making contacts via Arg155 and Arg162 guanidinium nitrogen atoms in E
(Arg155/162) forming hydrogen bonds to Leu57 carbonyl oxygen and Glu54 side chain
oxygen atoms in A, respectively. Helices B and C are connected by a long (22 residue)
loop, with the first ~10 residues (Gln72-Arg79) having poorly defined electron density.
The N77PxY80 motif, which is disordered in the structure, is located within this loop, and
stretches across helices C and D which, in turn, lie diagonally overtop helices A and E.
Thus, helices A and E act as a narrow scaffold upon which helices B, C and D are
positioned, with the longest loop of the structure (between helices B and C) rendered
solvent accessible.
Significant intermolecular contacts in the MavE crystal occur at the AA or BC dimer
interfaces. Each ~1000 Å2 interface is formed by N- and C-terminal residues, which

47

contact a kinked region of helix C in the symmetry-related molecule. Two centrally
positioned citrate molecules strengthen the BC dimer interaction using a water-mediated
hydrogen bond network. Residues contributing to this interaction are Ala38, Glu42,
Gln125 and Ser128 of each chain. The difference electron density map (mFo – DFc)
indicates the presence of another stabilizing element at the A-A interface, although the
identity of this small molecule remains unclear.
To gain insight into MavE function, we searched for proteins with a similar fold.
To this end, we submitted MavE (39-172) coordinates to the DALI server [300]. The most
interesting result in our search for homologues was a core domain of the grass pollen
allergen, Phlp 5b (PDB id 1L3P, Z-score = 7.1). This domain is comprised of a four-helix
bundle [301]. Helices A, B, C and D of MavE (39-172) align well with the Phlp 5b core
domain (Figure 2-8B), but helix E has no counterpart in Phlp 5b. Two 35-residue helixturn-helix motifs are present in Phlp 5b and they share 37% sequence identity with one
another. These motifs adopt remarkably similar helix termination and chain reversal
strategies.

As such, Phlp 5b was described as a twinned two-helix bundle.

The

corresponding helix-turn-helix motifs in MavE also share several residues, with some
stabilizing the core architecture. Based on these observations, MavE can be said to have a
similar core domain to that of Phlp5b. Interestingly, the extended loop between helices B
and E in MavE is not present in Phlp5b and constitutes an insertion into this fold. This
insertion contains not only the NPxY motif but also a triad Asp64-His68-Ser102 that is
reminiscent of the catalytic triad of serine proteases. Two of these residues are located
within the insertion loop. While these sidechains in the crystal structure are not connected
by hydrogen bonds (as they are in the catalytic triad of proteases), they could be brought
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into such interactions by simple rotation of the sidechains (Figure 2-8), suggesting a
possibility that MavE possesses catalytic activity.

Figure 2-8: Crystal structure of MavE (39-172). (A) Overall structure of a single
MavE chain. Helices A, B, C, D and E are colored red, yellow, pink, green and orange,
respectively. Loops are shown in grey. (B) Overlay of MavE (39-172) and the grass
pollen allergen Phlp 5b. MavE is colored as in A and the grass pollen allergen is colored
wheat. Hydrophobic core residues are depicted as sticks. (C) View of the overlay shown
in B from below. Note that helix E and the loop connecting it to B are absent in Phlp 5b.
The dimer interface for AA and BC chains is depicted in (D) and (E), respectively.
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Structure-based Functional Analysis of MavE
To determine the role the NPxY motif has in the function of the MavE effector
during infection, six-point mutations were made in the critical domains predicted to
contribute to the biochemical function of MavE. Three residues in the NPxY motif
(N77A, P78A and Y80A) were targeted for substitution. They are located on the
insertion loop, are exposed on the MavE surface and show high mobility/flexibility (poor
electron density). Three other residues (D64-H68-S102), which constituted a potential
catalytic triad reminiscent of the catalytic triad of serine proteases, were also targeted for
substitution mutagenesis. Growth of the mavE substitution mutants during in vitro broth
culture grew identical to the wild type strain (Figure 2-3B). The L. pneumophila
expressing mavE variants were used to infect hMDMs to evaluate intracellular growth
kinetics (Figure 2-10). Two of the substitution mutants, D64A and P78A, were found to
be attenuated (Figure 2-9A). Similar results were observed in A. polyphaga. An
additional substitution mutant, H68A, also showed attenuation in A. polyphaga (Figure
2-9B). Using immunoblots of total bacterial lysates, there was no major differences in
the expression and stability of the variant proteins in the L. pneumophila variants with
defective phenotypes (Figure 2-3C). Thus, the structure of the MavE protein harbors
several functional motifs including an NPxY eukaryotic motif, and these motifs are
required for the function of MavE in intracellular proliferation of L. pneumophila.
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Figure 2-9: The role of the NPxY motif in biological function of MavE in hMDMs
and A. polyphaga. (A) hMDMs and (B) A. polyphaga were infected with the WT
strain, the T4SS mutant, the mavE mutant, NPxY substitution mutants (D64A and P78A),
and complemented mavE mutant (mavE/C), and number of CFUs were determined at 2,
8, and 24 h post-infection. Data points represent (mean CFUs ± SD, n = 3) and are
representative of three independent experiments. Data points represent (mean
CFUs ± SD, n = 3) and are representative of three independent experiments. (Student ttest, * p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001)
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Figure 2-10: The role of the NPxY motif in biological function of MavE in hMDMs
and A. polyphaga. Showing all point mutations (A) hMDMs and (B) A. polyphaga
were infected to determine intracellular replication of the WT strain, the ΔT4SS mutant,
the mavE mutant, NPxY substitution mutants (D64A, P78A, S102A, Y80A, H68A and
N77A), the WT strain harboring the pBCsk vector, and complemented mavE mutant
(mavE/C), hMDMs. The number of CFUs was determined at 2, 8, and 24 h postinfection. Data points represent (mean CFUs ± SD, n = 3) and are representative of three
independent experiments done in triplicate. (Student t-test, * indicates p ≤ 0.05; ** p ≤
0.01; *** p ≤ 0.001).
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To determine if the mavE substitution mutants shown essential for intracellular
replication in hMDMs also exhibit altered phagosome biogenesis, we utilized confocal
microscopy to determine co-localization of the LCV with the ER marker, KDEL (Figure
2-11). The additional substitution mutant, H68A, shown to be attenuated in A.
polyphaga and substitution mutant, S102A, which did not show attenuation, were used as
controls. The data showed that 92% of LCVs harboring wild type bacteria co-localized
with KDEL, while only 12% of the mavE mutant strain-containing vacuoles co-localized
with the marker (Figure 2-11). Much like the mavE mutant strain-containing LCVs, 14%
of the D64A substitution mutant LCVs and 11% of the P78A substitution mutant LCVs
co-localized with KDEL. For the controls, 87% of the H68A substitution mutant and 90%
of the S102A substitution mutant containing LCVs co-localized with the ER marker
KDEL.
Importantly, ~90% of the LCVs containing the P78A and the D64A substitution
mutants’ bacteria co-localized with the LAMP1 marker, similar to the mavE mutant,
while only 7% of the wild type containing LCVs co-localized with the marker (Figure 212). The controls, S102 and the H68A substitution mutants’ LCVs showed 5-9% colocalization with LAMP1.
Our data showed that the D64A substitution mutant showed 70-75% colocalization with Cathepsin D, similar to the mavE mutant (Figure 2-13). Importantly,
66% of the P78A containing LCVs co-localized with Cathepsin D, similar to the mavE
null mutant (Figure 2-13). Only 8% of LCVs harboring the wild type strain localized
with the lysosomal marker Cathepsin D. Only 10-13% of the LCVs containing the H68A
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and S102A substitution mutants co-localized with Cathepsin D. Importantly, similar to
the mavE mutant, the majority of the P78A and D64A substitution mutant bacteria
exhibited altered morphology with exaggerated rounding and blebbing, indicative of
bacterial degradation and consistent with fusion of the LCV to the lysosomes. Taken
together, the two substitution mutants, D64A and P78A, phenocopied the mavE null
mutants in failure to create ER-derived vacuoles that bypass the lysosomal degradation
pathway, and to proliferate in hMDMs. Thus, the P78 residue within the NPxY motif and
the D64 residue are required for the function of MavE in phagosome biogenesis and
lysosomal evasion.
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Figure 2-11: Remodeling of the vacuoles with the ER. Representative confocal
microscopy images of co-localization of the LCVs containing wild type, mavE mutant, or
NPxY substitution mutants; D64A, H68A, P78A, and S102A strains labeled with the ER
marker, KDEL (green), DAPI (blue) and anti-Legionella (red). Quantification of colocalization with the LCV (indicated by arrowheads-yellow) is shown in merged images.
All analyses were performed on 100 infected cells analyzed from multiple cover slips. The
results are representative of three independent experiments performed in triplicate.
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Figure 2-12: Fusion of the vacuoles containing the mavE substitution mutants with
the late endosomes/lysosomes. Co-localization of the LCVs containing wild type, mavE
mutant, or the NPxY substitution mutants; D64A, H68A, P78A, and S102A strains with
the late endosome/ lysosomal marker, LAMP1 (green), DAPI (blue) and anti-Legionella
(red). Quantification of co-localization with the LCV (indicated by arrowheads-yellow)
is shown in merged images. All analyses were performed on 100 infected cells analyzed
from multiple cover slips. The results are representative of three independent
experiments performed in triplicate.
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Figure 2-13: Fusion of the vacuoles containing the mavE substitution mutants with
the lysosomes. Co-localization of the LCVs containing wild type, mavE mutant, or the
NPxY substitution mutants; D64A, H68A, P78A, and S102A strains with the lysosomal
marker, Cathepsin D (green), DAPI (blue) and anti-Legionella (red). Quantification of
co-localization with the LCV (indicated by arrowheads-yellow) is shown in merged
images. All analyses were performed on 100 infected cells analyzed from multiple cover
slips. The results are representative of three independent experiments performed in
triplicate.
57

Discussion
Intracellular pathogens, whether cytosolic or intra-vacuolar within macrophages
have evolved with various idiosyncratic mechanisms to evade various innate defense
processes to avoid degradation within macrophages [230, 302-304]. These pathogenic
mechanisms involve the injection or secretion of pathogenic effectors into the host by
various secretion or injections apparatuses designated type I-IX translocation system [305308], and are present in extracellular pathogens, such as Bordetella [309], as well. These
effectors modulate various cellular processes as well host metabolism to render the host
cell suitable as a proliferative nutrient-rich niche [302, 310-316]. Cytosolic pathogens,
such as Rickettsia, have evolved to evade the host cytosolic anti-microbial processes [317,
318]. Modulation of host metabolism is a general common theme among intracellular
pathogens, leading to suitable nutritional niche for pathogen proliferation, and that has been
well characterized for Mycobacterium [297, 311, 312, 319-321].

For intra-vacuolar

pathogens, the crux of these host processes is evasion of the endosomal-lysosomal
degradation pathway by most intra-vacuolar pathogens, such as Mycobacterium,
Chlamydia, and Salmonella [235, 270]. Modulation of the macrophage autophagy [322]
and M1 vs. M2 polarization by intracellular pathogens [89] is an emerging theme to
modulate the host inflammatory response [323, 324].

The intra-vacuolar pathogen, L.

pneumophila resides within the LCV that seems to be excluded from the endocytic pathway
and is more of an ER-like comportment than a phagosome [203, 235]. While there are
numerous studies on translocated effectors of L. pneumophila and few of them have a
partial role in lysosomal evasion, none of the effectors are indispensable for lysosomal
evasion [166, 203, 325].

With few exceptions, single effector deletions for most
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characterized effectors of L. pneumophila do not exhibit a defective intracellular growth
phenotype [326]. Redundancy among the L. pneumophila effectors occurs in different
manners and deletion of redundant paralog effectors does not always impair intracellular
growth [206-208]. Here, we show MavE is the first effector to be indispensable for both
phagosome biogenesis and lysosomal evasion by L. pneumophila. The altered LCV
biogenesis of ER remodeling in absence of MavE could be an indirect by-product of the
altered lysosomal evasion. MavE is localized at the cytosolic side of the LCV poles and is
likely functioning in subverting vesicular fusion with the endocytic pathway. It has been
shown that polar localization is a key feature of virulence of L. pneumophila, and this
polarity could result in an increased localized concentration of sub-domain of certain
effectors at the LCV pole; possibly meeting a critical threshold concentration necessary for
effector activity [173]. Although ER remodeling of the LCV and its lysosomal evasion are
independent processes, it is not known which comes first [327]. LCVs communicate with
and modulate the secretory vesicle trafficking pathway; however, little is known about the
temporal aspect of ER remodeling and lysosomal evasion by the LCV [327].
The MavE structure contains a core domain reminiscent of the grass pollen allergen,
Phlp 5b. Comparing to allergen Phlp 5b, MavE contains a long insertion loop located
between helix B helix C. These insertions represent a region of functional significance to
MavE, as their absence in Phlp 5b suggests it is dispensable for protein stability. It has
been suggested that the compactness of the twinned two-helix core domain facilitates
proteolytic resistance in Phlp 5b [301]. In accordance with this notion, MavE may have
evolved this domain to act as a robust scaffold for displaying functional elements to binding
partners. The fact that Phlp 5b retains allergenicity can further rationalize this claim, as L.
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pneumophila effectors must resist innate immune defenses.

This stability might be

essential for effectors performing a critical function in virulence, especially those having
no redundant counterpart.
Structural features outside the MavE core domain are of functional significance to
this protein. The loop connecting helices B and C is the longest in our model and contains
a region of conformational heterogeneity, as evidenced by high B-factors and the absence
of clear electron density. Intriguingly, the B-C loop harbors an NPxY sequence, which is
the canonical phosphotyrosine-binding (PTB)-domain interacting motif [328].

The

presence of this motif on a flexible, solvent exposed loop in MavE may suggest a role for
this protein in recruiting PTB-domains, which predominantly exist on adaptor or scaffold
proteins [294]. The two substitution mutants, D64A and P78A, are essential for MavE
function within hMDMs and A. polyphaga, with an additional mutant, H68A to be
essential in amoebae. Neither the N77A nor Y80A variants significantly impede L.
pneumophila replication within hMDMs, whereas all three NPxY motif variants are
similarly attenuated in A. polyphaga. The attenuated replication of the D64A and H68A
substitution mutants can be explained by disrupting the putative activity of MavE.
However, it is plausible that certain substitution of residue (D/H) for a nonpolar one (A)
may alter the structure due to differences in electronegativity. Our findings highlight the
significance of the NPxY motif, and specifically P78, to the function of MavE and possible
L. pneumophila divergence between human and amoebae hosts. The variation between
essential MavE function within hMDMs and A. polyphaga of the substitution mutants may
be due to the evolutionary distance between host cells. The evolution of amoeba hostspecific effectors that modulate amoeba-specific cellular processes by L. pneumophilia
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may explain why only two substitution variants of MavE result in loss of its function in
biogenesis of the LCV in hMDMs.
The proline residue within NPxY has been shown to form a β-turn structure that
distinguishes this motif from the similar NxxY sequence, which is also recognized by
adaptor proteins [329]. This structural distinction between NPxY and NxxY provides a
source of specificity for adaptor proteins [330]. Our results suggest that the NPxY motif
of MavE has a β-turn structure that is critical for its interaction with host adaptors as well
as metaeffector(s). Further investigation of these host adaptors and other PTB-domain
containing proteins that are selective for NPxY motifs will provide additional insight into
the role of MavE.
The primary hosts of L. pneumophila are lower eukaryotes, such as free-living
amoebae, which encode a small number of PTB-domain containing proteins [331]. Only
two PTB-domain containing proteins are present in Dictyostelium discoideum, namely
Talin A and B [294]. These proteins link the cytoplasmic domains of integrin β-subunits
to actin filaments, and thereby promote the formation of cellular junctions with the
extracellular matrix. Acanthamoeba castellanii, a natural host of L. pneumophila, also
encodes a putative Talin protein [332]. Since Talin is the only PTB-domain containing
protein found in the natural hosts of Legionella, MavE may interfere with host processes
requiring functional Talin [294]. Specifically, the recruitment of Talin by MavE could
disrupt the organization of host actin [333] and thus alter the standard progression of
vacuolar biogenesis events. In this way, MavE may participate in evasion of LCVlysosome fusion.
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Helices B and C of MavE (39-172) contain S102, H68 and D64 in a negatively
charged pocket on the protein surface. Although these residues do not conform to the
hydrogen bond network characteristic of a serine protease catalytic triad [334], their
divergence from this pattern may be an artifact of crystal packing. Indeed, conformational
changes in the flexible loop connecting B and C may affect the orientation of these two
helices relative to one another. In addition, the loop connecting C and D is unclear in the
electron density, suggesting flexibility in this region. Since movement of this loop would
affect the orientation of C, this too could contribute to structural changes required to form
the canonical catalytic triad.

It is possible that our C-terminal truncation produced

conformational changes in the soluble domain of MavE, which widen the putative active
site and render it non-catalytic. Alternatively, the catalytic triad containing Ser102, His68,
and Asp64 found in MavE may not exhibit a protease catalytic activity. Further studies
evaluating the proteolytic activity of MavE will be informative.
In summary, our data show that MavE is involved in the acquisition of ER-derived
membranes by the LCV and in evasion of lysosomal fusion. It is likely that both functions
depend on the NPxY motif located within a solvent exposed loop on the MavE structure.
By mediating interactions with adaptor proteins, the NPxY motif of MavE may coordinate
LCV trafficking through interaction with host adapter proteins and other L. pneumophila
metaeffectors such as YlfA/LegC7. Because of the unusually large repertoire of effectors,
it is likely that additional L. pneumophila effectors also function to facilitate lysosomal
evasion by the LCV [277, 292, 335]. These effectors are likely to function in concert with
temporal coordination among the effectors to enable ER remodeling and lysosomal evasion
of the LCV. Future studies identifying any key players that interact with MavE as a
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complex and function with MavE in lysosomal evasion will generate a broader
understanding of the main virulence strategy utilized by L. pneumophila.

Materials and Methods
Strains and cell lines
L. pneumophila strain AA100/130b (ATCC BAA-74), and the T4SS-deficient
mutant (lspG) were grown on BCYE agar [261]. To generate an isogenic mavE deletion
mutant, 2 kb of DNA flanking either side of the mavE gene was amplified using PCR
using primers listed in Table 1 and cloned into the shuttle vector, pBCSK+ (StrateGene),
resulting in pBCSK+mavEKO1. To delete the entire mavE gene within pBCSKmavEKO1, inverse PCR was employed using primers listed in Table 1, resulting in a
pBCSK+mavEKO2. The kanamycin resistance cassette from the Ez-Tn5 transposon was
amplified using primers listed in Table 1 and the resulting PCR product was subcloned
into pBCSK+mavEKO2 in between the mavE flanking DNA regions using standard
molecular biology procedures, resulting in pBCSK+mavEKO3. This plasmid was
introduced into L. pneumophila AA100 via natural transformation, as described
previously[216]. Following 3 days, natural transformants were recovered by plating on
BCYE agar supplemented with 50 µg/ml kanamycin. To confirm deletion of the mavE
gene in the transformants, PCR was used using the primers listed in Table 1. To
complement the mavE mutant, PCR was used to amplify the mavE gene and its upstream
promoter region using primers listed in Table 1, and subcloned into pBCSK+, generating
pBCSK+mavE/C. This plasmid was introduced into the mavE mutant via electroporation
as described previously[336]. Complemented mavE mutants were selected on BCYE
plates supplemented with 5 µg/ml chloramphenicol, resulting in the complemented strain,
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mavE/C. For infections of cell monolayers, L. pneumophila was grown in BCYE agar
plates with appropriate antibiotic selection at 37°C for 3 days prior to use in infections, as
described previously [337]. Human monocyte-derived macrophages (hMDMs) were
isolated from healthy donors and cultured in RPMI 1640 (Corning Cellgro) as described
previously [337, 338]. HEK293T cells (ATCC) were cultured in DMEM (Gibco)
supplemented with 10% fetal bovine serum as previously described [337, 338]. All
methods were carried out and approved in accordance with the University of Louisville
Institutional Review Board guidelines and blood donors gave informed consent as
required by the University of Louisville Institutional Review Board (IRB # 04.0358).
TABLE 1
Primers used in this studya
Primerb
Orientationc

Sequence

Primers used to clone mavE and flanking DNA to generate the mavE mutant (pBCSK plasmid)
MavE KO

F

GTCGACAGGTAATTTCTGATAATGAAC

MavE KO

R

TCTAGAATAGAGCCGTTGGAAGAAAGT

Primers used for inverse PCR to delete mavE from the above fragment to make the mavE mutant
MavE KO

F

aaatttGTTTAAACGGAAGTGTTTACAGGATT

MavE KO

R

CCTGCAGGAGGTAGTGTTTTATACTAA

Primers used to clone into pBCSK to complement the mavE mutant
MavE/C

F

AAGCTTATTATATAATGATTTATCAATTT

MavE/C

R

GGATCCTATTTGGTCCATCTTGAAC

Primers used to confirm KO of mavE in L. pneumophila
MavE KO test

F

TTTTATATCTTTAGGTTCATTCA

MavE KO test

R

CTTGAAACGACCGTATTTG

Primers used for cloning into the p3XFLAG vector for eukaryotic expression
3XFLAG mavE

F

AAGCTTCTGACTCGATTCATAATGCTTT

3XFLAG mavE

R

AGATCTTTATGGTTTGTTGCCAAACAAC

Primers used for cloning into the 4HA vector for bacterial expression
HA MavE

F

ggatccCTGACTCGATTCATAATGC

HA MavE

R

aagcttTTATGGTTTGTTGCCAAACA

a

All primers are 5′-phosphorylated.
KO, knockout.
c
F, forward; R, reverse.
b
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DNA manipulations
DNA manipulations, generation of MavE substitutions, and restriction enzyme
digestions were performed using standard procedures [338, 339]. L. pneumophila WT
expression HA4-PieE were obtained from MRC Centre for Molecular Bacteriology and
Infection. The MavE construct replaced the PieE sequence using the same methods and
restriction sites previously described [340]. Restriction enzymes and T4 DNA ligase
were purchased from NEB (Madison, WI). Plasmid preparations were performed with
the PureLink HiPure Plasmid Maxiprep kit (Invitrogen). Purification of DNA fragments
from agarose gels for subcloning was carried out with the QIAquick gel purification kit
(Qiagen Inc, Valencia, CA).
Intracellular replication in hMDMs and Amoeba
For infection of cell monolayers, L. pneumophila strains were grown in BYE
broth with appropriate antibiotic selection, at 37 °C with shaking, to post-exponential
phase (OD550nm 2.1–2.2). A. polyphaga (ATCC) was cultured in PYG media at 22 °C,
experiments were performed in PY media at 35 °C, as previously described [337].
Human monocyte-derived macrophages (hMDMs) were isolated from healthy donors and
cultured in RPMI 1640, supplemented with 10% fetal bovine serum, as previously
described [337, 338]. The wild type strain; the isogenic mutants, T4SS and mavE; and
complements mavE/C, mavE/Y80, mavE/H68, mavE/P78, mavE/N77, mavE/D64, mavEpBCsk, mavE-4HA, and WT-pBCsk were grown to post-exponential phase in BYE broth
at 37 °C with shaking prior to infection and used to infect hMDMs and A. polyphaga, as
previously described [337, 338]. A total of 1 × 10 5 host cells were plated in 96 well
plates and infected with L. pneumophila at an MOI of 10. Plates were centrifuged at
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200 × g (5 mins), to synchronize infection. After 1 h, cells were treated with gentamicin
to kill extracellular bacteria, as previously described [337, 338]. Over a 24 h time course,
host cells were lysed with sterile water (hMDMs) or 0.02% v/v Triton X-100 (A.
polyphaga). L. pneumophila CFUs were determined by plating serial dilutions onto
BCYE agar.
Transfection of HEK-293 cells (ATCC)
The mavE gene was cloned into the mammalian expression vector, p3XFlagCMV-10 (Sigma). To generate the mavE-9L10P/AA allele, the wild type p3XFlag-CMV10 MavE plasmid was used as a template for PCR based site directed mutagenesis. HEK293 cells (ATCC) were grown to 80% confluency and plated onto poly-L-lysine-treated
coverslips in 24 well plates. Following 24 h of incubation, HEK293T cell monolayers
were transfected with ~2 µg of plasmid DNA encoding 3X-FLAG MavE/well by using
polyethylenimine (Polysciences) for 24 h, following the manufacturer's recommendations
(Roche) as previously described [341, 342].
Mouse model
For testing the virulence of the mavE mutant, specific pathogen-free, 6–8 weeks
old A/J mice (Jackson) were used, as previously described [338, 343]. Groups of 3 A/J
mice, for each time point, were infected intratracheally with 1 × 10 6 CFUs. The wild type
strain: the isogenic mutant mavE and complemented mavE/C strains, were grown to postexponential phase on BCYE plates at 37 °C for 72 hours prior to infection and used to
infect A/J mice. At 2, 6, 12, 24, 48, and 72 h after infection mice were humanely
sacrificed and lungs, liver, and spleen were harvested and homogenized in sterile saline
(5 ml) followed by cell lysis in distilled water. To determine CFUs, serial 10-fold
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dilutions were plated on BCYE agar and incubated at 37 °C for 72 hours and colonies
were enumerated. The percent survival was recorded for groups of 5 A/J mice infected
using an inoculation of 1 x 107 CFUs (LD50) for WT, mavE, and mavE/C strains from 0
to 10 days post-infection. All the experimental procedures were in accordance with
National guidelines and were approved by the Institutional Animal Care and Use
committee (IACUC) at Faculty of Medicine, University of Rijeka. To determine any
level of difference between groups, a value of “E” (the degree of freedom of analysis of
variance or ANOVA), which should lie between 10 and 20 was determined to be 12
based off our sample size. (E = total number of animals - total number of groups).
Confocal microscopy
Processing of infected cells for confocal microscopy was performed as we
described previously [338]. 4HA-tagged MavE constructs in both wild type and T4SS L.
pneumophila were analyzed for confocal following 1hr infection in hMDMs. Colocalization of the LCVs containing WT, FK-WT, mavE; and complements mavE/C,
mavE/Y80, mavE/H68, mavE/P78, mavE/N77, mavE/D64, mavE-pBCsk, and WT-pBCsk
were analyzed for confocal following 2hr infection in hMDMs. Cells were prepared
using the same protocol for intracellular replication except 2 x 10 5 host cells were plated
on coverslips in 24 well plates. The monolayers were infected with L. pneumophila at an
MOI of 10. Plates were centrifuged at 200 × g (5 mins), to synchronize infection. After
1 h, cells were treated with gentamicin to kill extracellular bacteria, as previously
described [337, 338]. For 4HA-tagged MavE constructs, following fixation in 10%NBF,
the plasma membranes of infected hMDMs were differentially permeabilized using
digitonin at 1 mg/ml in KHM Buffer. Incubated for exactly 1 min at RT and immediately
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washed all wells 3x with 0.5 ml of KHM Buffer [344]. For all other confocal
experiments, cells were fixed in -20 ̊C methanol for 5 minutes and rinsed 3x in 10% PBS.
For antibody labeling for MavE, mouse anti-L. pneumophila was used at a dilution of
1:500 and detected by Alexa-Fluor 488-conjugated donkey anti-mouse IgG (1:1000)
(Invitrogen, Carlsbad, CA) and rabbit anti-MavE (ThermoFisher Scientific) was used at a
dilution of 1:500 and detected by Alexa-Fluor 555-conjugated donkey anti-rabbit IgG
(1:1000) (Invitrogen, Carlsbad, CA). For antibody labeling for localization, rabbit anti-L.
pneumophila was used at a dilution of 1:750 and detected by detected by Alexa-Fluor
555-conjugated donkey anti-mouse IgG (1:1000)(Invitrogen, Carlsbad, CA) mouse
monoclonal anti-Cathepsin D (abcam) was used at a dilution of 1:200 and detected by
Alexa-Fluor 488-conjugated donkey anti-mouse IgG (Invitrogen, Carlsbad, CA), mouse
monoclonal anti-KDEL (enzo) was used at a dilution of 1:200 and detected by AlexaFluor 488-conjugated donkey anti-mouse IgG (Invitrogen, Carlsbad, CA) at a 1:1000
dilution, mouse monoclonal anti-Lamp 1 (abcam) was used at a dilution of 1:200 and
detected by Alexa-Fluor 488-conjugated donkey anti-mouse IgG (Invitrogen, Carlsbad,
CA) at a dilution of 1:1000. For detection of 3X-FLAG tagged proteins during
transfection experiments, mouse monoclonal anti-FLAG (Sigma) antibodies were used
followed by detection with Alexa-Fluor 555-conjugated donkey anti-mouse (Invitrogen,
Carlsbad, CA) at a 1:1000 dilution. DAPI was used for all experiments at a 1:5000
dilution. An Olympus FV1000 laser scanning confocal microscope was used in house to
examine cells as we described previously [298]. On average, 10–20 0.5 µm serial Z
sections of each image were captured and stored for further analyses, using Adobe
Photoshop CS3. A total of 100 infected cells for each replicate were manually counted
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for presence or absence of localization and a percentage given. A total of 3 biological
repeats were analyzed for the presence or absence of localization.
Cloning of recombinant MavE
The MavE (Lpg2344) gene was amplified from Legionella pneumophila
(Philadelphia) genomic DNA by PCR. Residues 183 – 204 are predicted to comprise a
transmembrane (TM) region (Program Phobius) [345]. To clone only the soluble domain
of MavE, we amplified the DNA sequence encoding residues 2 – 172. This construct
terminates just after the final hydrophilic helical stretch and excludes the following loop
and TM region. The MavE (2-172) insert DNA sequence was placed into pMCSG7 and
pRL652 vectors by ligation independent cloning (LIC), incorporating an N-terminal
TEV-cleavable His6- or GST-tag, respectively [346, 347]. His6-MavE (2-172) expressed
poorly in BL21 (DE3) pLysS (promega) and GST-MavE (2-172) did not readily bind the
glutathione resin. Running PsiBLAST on MavE showed that most homologous proteins
have start sites corresponding to residue M38. To explore the possibility of a
misannotated start site, we amplified MavE (39-172) using the following primers:
Sense: 5'TACTTCCAATCCAATgccACTAGATTTGAAAGAAATTTCCTGATTAATAGC-3'
Antisense: 5'TTATCCACTTCCAATgTTATTCGTCTTTGAGTTTGGCAATTAATTCTT-3'. As
previously described, the MavE (39-172) DNA insert was placed into pMCSG7 and
pRL652 vectors via LIC using the extensions underlined above. This construct of MavE
was used for expression, purification and crystallization trials.
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Protein Expression and Purification
His¬6-MavE (39-172) was transformed into chemically competent BL21 (DE3)
pLysS cells and plated on LB agar containing ampicillin (100 µg/ml). A single
transformant was inoculated into 20 ml of LB supplemented with ampicillin (100 µg/ml)
and glucose (0.4%), and grown overnight at 37°C. This overnight culture was subcultured into 1 L of terrific broth (TB) supplemented with ampicillin (100 µg/ml) and
grown at 37°C. Once the cell culture reached an optical density (A600) of ~1.0, the
temperature was reduced to 18°C, 1 mM of Isopropyl β-D thiogalactopyranoside (IPTG)
was added to the culture to induce protein expression and the cells were incubated for
approximately 16 more hours. Cells were pelleted at 6900 x g for 15 minutes in a
Beckman JLA 8.1000 rotor and stored at -80°C until further processed. Approximately
10 grams of pellet was obtained from 1 L of culture. Cells were re-suspended in 30 ml of
a lysis buffer (50 mM Tris, pH 8.0, 10% (v/v) glycerol, 0.1% (v/v) Triton X-100) and
lysed two times at 35 kPsi in a cell disruptor (Constant Cell Disruption Systems,
Kennesaw, Georgia). The lysate was spun at 21000 x g for 30 minutes in a Beckman
JA25.50 rotor. Supernatant was added to 5 ml of Qiagen NiNTA beads pre-equilibrated
with three column volumes of a standard buffer (20 mM Tris, pH 8.0, 50 mM NaCl) and
the beads were washed with 50 ml of standard buffer. Protein was eluted with standard
buffer supplemented with 100 mM imidazole. Purified protein was concentrated to 18
mg/ml in a 10 kDa molecular weight cut-off Millipore centrifugal filter at 4000 x g. The
hexahistidine tag was cleaved by adding 100 µl TEV protease to 500 µl concentrated
MavE and incubating overnight at room temperature. Untagged MavE was then loaded
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onto a Biorad SEC70 or GE SEC75 column for buffer exchange and further purification.
Peak fractions were collected and concentrated to 25mg/ml for crystallization.
A seleno-methionine derivative of MavE (38-172) was produced by inhibiting
methionine biosynthesis immediately prior to induction. Specifically, 100 mg lysine,
phenylalanine and threonine and 50 mg isoleucine, leucine and valine were added to 1 L
of culture 15 minutes prior to induction. 60 mg L-seleno-methionine was also added to
the culture, such that this version of methionine would be incorporated into
overexpressed MavE during induction.
Crystallization
Both His¬6-MavE (39-172) and MavE (39-172) were screened for crystallization
using Crystal Screen HT, Index (Hampton Research, Aliso Viejo, CA), JCSG Core II and
Classics Suite (Qiagen, Toronto, Canada). His6-MavE (39-172) did not crystallize under
any of the conditions tested, whereas MavE (39-172) produced crystals under several
conditions. After optimization by the hanging drop vapor diffusion method, the best
crystals were obtained at 20°C in drops containing 1 µl protein in 15 mM Tris-HCl, pH
8.0, 50 mM NaCl mixed with 1 µl of reservoir solution (10% PEG 20000, 0.1 M Citrate,
pH 3.0) and suspended over 500 µl reservoir solution.
Data Collection and Structure Solution
The protein crystals were cryo-protected by transferring to 1 µl mother liquor
containing 20%(v/v) ethylene glycol. Diffraction data was collected to 1.8Å at the
Canadian Macromolecular Crystallography Facility (CMCF) 08ID beamline, Canadian
Light Source, using a MAR300CCD Detector [348]. Integration and scaling was carried
out using the XDS software package [349] (autoprocess). MavE (39-172) harbours only
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one methionine at residue 51 and substitution of this residue for seleno-methionine
produced sufficient anomalous signal to solve the structure by single anomalous
dispersion (SAD) using the phenix. autosolve script. Refinement of the structure was
carried out using phenix. refine [350].
Statistical analysis
All experiments were performed at least three independent biological repeats, and
the data shown are representatives of one experiment.

To analyze for statistically

significant differences between three sets of data, the two-tailed Student’s t-test was used,
and the p-value was obtained. (* indicates p ≤ 0.05; ** indicates p ≤ 0.01; *** indicates p
≤ 0.001)
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CHAPTER 3:
MAVE INTERACTION WITH HOST PROTEIN ACBD3
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Introduction
L. pneumophila has evolved with virulence strategies that use its T4SS secreted
effectors to parasitize protozoa and confers the ability to replicate within human phagocytic
cells [351]. L. pneumophila employs over 350 translocated effectors into the host cell
cytosol by the T4SS [158, 186, 286], which are essential for the biogenesis of the LCV,
intracellular replication, and prevention of lysosomal degradation. The L. pneumophila
effectors constitutes the largest arsenal of translocated effectors proteins by any bacterial
pathogen [211]. Equipped with these effectors, L. pneumophila proliferates to high
numbers within its host. Comparative experiments with several infection models including
its natural amoeba host and human macrophages have shown that the modulation of diverse
host cell functions by the Dot/Icm-translocated effectors are a prerequisite for biogenesis
of the LCV [352].
Remarkably, host responses upon contact with L. pneumophila starts as early as
phagocytosis [155]. Mutants of L. pneumophila lacking the response regulator effector
LetA are phagocytosed less efficiently by both D. discoideum and macrophages [353].
Once phagocytosis is complete, the development of an ER-associated LCV is initiated by
several L. pneumophila Dot/Icm injected effector proteins. These effectors modulate
biogenesis of the LCV by recruiting and altering the composition of phosphoinositides on
the LCV membrane along with various GTPases of the Rab and Arf families (Figure 1-3)
[352]. An example of this is the ubiquitination and recruitment of Rab10 to the LCV by
the SidC/SdcA effector [354]. Manipulation of ER-to-Golgi transport machinery to recruit
ER-derived vesicles to the LCV is vital to the biogenesis of the replicative LCV [129].
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Therefore, it is likely L. pneumophila modulate ER-to-Golgi vesicle traffic by specific
effectors.
One of the host regulators of ER-to-Golgi vesicle traffic is the Acyl-Coenzyme A
Binding Domain Containing 3 (ACBD3).

Other designations for this protein are:

peripheral-type benzodiazepine receptor and cAMP-dependent protein kinase associated
protein 7 (PAP7), Golgi complex-associated protein of 60kDa (GCP60), Golgi complexassociated protein 1 (GOCAP1), and Golgi phosphoprotein 1 (GOLPH1) [355].
Interestingly, two effector proteins of the intracellular pathogen Salmonella, Ssef and
SseG, interact with the host ACBD3 protein, tethering the Salmonella containing vacuole
(SCV) to the Golgi [356].
ACBD3 is a Golgi-resident multifunctional protein involved in the maintenance of
the Golgi apparatus and functions by recruiting the lipid kinase Phosphatidylinositol 4kinase beta (PI4KB). Together with the PI4K2A enzyme, PI4KB synthesizes
phosphatidylinositol-4-phosphate (PI4P) [355, 357-359]. ACBD3 consists of several
domains and it’s Golgi dynamics (GOLD) domain is localized at the C-terminus and serves
as a protein-binding site to most reported ACBD3-interacting proteins (giantin, TSPO,
Rhes, PKARIα, and Golgin-160) [355, 357, 360]. Thus, ACBD3 functions as an adaptor
protein and signaling center across diverse signaling pathways to regulate myriad of
cellular processes including apoptosis, homeostasis, and lipid homeostasis [357]. PI4KB
is a soluble cytosolic protein whose primary function is to phosphorylate membrane lipids
and generate PI4P [358, 361].

PI4P is an essential lipid found in various membrane

compartments including the Golgi, trans-Golgi network (TGN), plasma membrane,
endocytic compartments, and the LCV [357, 362]. L. pneumophila exploits PI4P to anchor
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other injected effector proteins to the LCV to subvert host cell phosphoinositides (PI)
metabolism, which is essential for establishment of the replicative LCV [362].
The ACBD3 protein recruits the ER-resident transmembrane protein phosphatase
(PPM1L) to ER-Golgi membrane contact sites [363], where PPM1L dephosphorylates the
ceramide transport protein CERT and regulates ceramide transport [363]. Ceramide is
hydrolyzed and phosphorylated yielding sphingolipids [364], which are membrane lipids
involved in interaction of various bacterial pathogens with the host cell [364]. Bacterial
pathogens that cannot synthesize sphingolipids, including Mycobacteria, Pseudomonas,
Neisseria, Helicobacter, Chlamydia, and Legionella, have developed different strategies
to manipulate host sphingolipids to promote their pathogenicity [365]. L. pneumophila
modulates the host cell sphingolipid metabolism, affecting the level of sphingosine by
secreting LpSPL that encodes sphingolipid lyase activity in both transfected cells and
infected macrophages. [366]. LpSPL targets the host’s sphingolipid metabolism and
restrains starvation-induced autophagy during L. pneumophila infection to promote
intracellular survival by acting on autophagosome biogenesis [366]. Given the importance
of lipid metabolism modulation by L. pneumophila during infection, ACBD3 is an
excellent candidate to further understand the biogenesis of the LCV.

Results
Identification of the MavE-interacting Host Proteins
To identify host proteins that interact with the L. pneumophila translocated effector
protein MavE, the proximity-dependent biotin identification (BIOID) strategy was
employed [367]. This method is based on proximity-dependent cellular biotinylation of
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neighboring proteins (with a practical labeling radius of ~25nm) by a promiscuous bacterial
biotin ligase fused to a bait protein (BIOID2) to identify protein-protein interactions in
living cells [367]. A fusion of BIOID2 with MavE harboring a cMyc tag was generated
(Figure 3-1A). Plasmids containing BioID2 alone (negative control) or MavE-BioID2
were used to transiently transfect human embryonic kidney (HEK293T) cells for 24hours.
The biotinylated proteins were then purified from the cellular lysates of two biological
replicates and identified using mass spectrometry (Table 2). Among the proteins solely
identified in the MavE-BioID2 samples was a peptide sequence fragment (MAAVLNAER)
that is exclusive to host protein ACBD3 (Figure 3-1B). The biotinylated peptide represents
a 98% probability for the presence of ACBD3 and for positive protein identification, the
mascot score must be above a 95% confidence level [368].
To confirm interaction of MavE with host protein ACBD3, pacGFP1-C1-MavE and
pacGFP1-C1 was constructed and used to transfect HEK293T cells. The MavE-interacting
host proteins were purified using magnetic beads conjugated with anti-GFP antibody and
subjected to immunoblot with anti-ACBD3 antibody. The immunoblot showed that
ACBD3 was specifically pulled down when MavE was ectopically expressed (Figure 3-2).
A small amount of background ACBD3 was observed in the GFP pulldown however this
is likely indicative of spillover from the total cell lysate containing a high concentration of
ACBD3.
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TABLE 2
Biotinylated host-MavE interacting protein identified by Mass Spectrometry
Protein

Identification Probability
(Sample #1/ Sample #2)

Isoform 2 of Ras-related protein Rab-8A

87% /13%

Function: The small GTPases Rab are key regulators of intracellular membrane trafficking, from the
formation of transport vesicles to their fusion with membranes.

AP-1 Complex subunit beta*

100%

Function: Subunit of clathrin-associated adaptor protein complex 1 that plays a role in protein sorting in
the late-Golgi/trans-Golgi network (TGN) and/or endosomes

GCP60/ACBD3

98%/24%

Function: Involved in the maintenance of Golgi structure by interacting with giantin, affecting protein transport
between the endoplasmic reticulum and Golgi

Serine/threonine- protein phosphatase 2A*

98%

Function: PP2A is the major phosphatase for microtubule-associated proteins (MAPs)

Arfaptin-2*

99%

Function: Plays a role in constitutive metalloproteinase (MMP) secretion from the trans Golgi network. May have
important functions during vesicle biogenesis at certain cargo subdomains, which could be predominantly utilized
by secreted MMPs, such as MMP7 and MMP2

Transmembrane emp24 domain- containing protein 5*

92%

Function: Potential role in vesicular protein trafficking, mainly in the early secretory pathway. Required for the
maintenance of the Golgi apparatus; involved in protein exchange between Golgi stacks during assembly. Probably
not required for COPI-vesicle-mediated retrograde transport.

Ras-related C3 botulinum toxin substrate*

85%

Function: Plasma membrane-associated small GTPase which cycles between an active GTP-bound and inactive
GDP-bound state. In active state binds to a variety of effector proteins to regulate cellular responses.

*Only identified in 1 of the MavE-BioID2 biological repeat samples
For positive protein identification probability must be above a 95% confidence level
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Figure 3-1: MavE interacts with host protein ACBD3. (A) Diagram of BioID2, in
yellow, and fusion with MavE, in blue. The line represents a poly-glycine linker, and the
green box represents a cMyc tag. (B) Mass spectrum of peptide sequence fragment
captured from biotinylated proteins generated during ectopic expression of MavE-BioID2
and purified with streptavidin magnetic beads. This peptide sequence (MAAVLNAER)
had a 98% probability in one biological repeat and is exclusive to ACBD3 also known as
Golgi resident protein GCP60.

Figure 3-2: Western Blot Analysis of MavE interacts with host protein ACBD3 during
ectopic expression. HEK293T cells were utilized to ectopically express MavE-GFP or
GFP. Cell lysates were immunoprecipitated (IP) with magnetic anti-GFP beads and the IP
was immunoblotted using anti-ACBD3 antibody to detect the presence of ACBD3 in the
pulldown of MavE-GFP. TCL stands for total cell lysate. Results are representative of two
independent experiments.
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Co-localization of ACBD3 with the Legionella containing vacuole in hMDMs
The MavE effector is localized to the LCV membrane at the poles of the vacuole.
Since ACBD3 interacts with MavE during ectopic expression, we determined if ACBD3
co-localizes with the LCV during infection using human monocyte derived macrophages
(hMDMs). We utilized confocal microscopy to determine co-localization of the LCV with
the ACBD3 at 1 hour post infection. The data showed that over 95% of LCVs harboring
wild type bacteria co-localized with ACBD3, while only 16% and 11% of the mavE mutant
and ΔT4SS-containing vacuoles, respectively, co-localized with the ACBD3 (Figure 3-3).
Much like WT-containing LCVs, 86% of the complemented mutant (mavE/C) containing
LCVs co-localized with ACBD3. We conclude that ACBD3 co-localizes with the LCV in
a MavE-dependent manner.

ACBD3 gene silencing in HEK293T and hMDMs
MavE is indispensable for lysosomal evasion of the LCV and interacts with the
host-ACBD3 protein. We wanted to determine the effect of silencing host protein ACBD3
on LCV biogenesis. We utilized an ON-TARGETplus Human ACBD3 siRNA pool and
non-targeting pool to knockdown expression of ACBD3 in hMDMs (Table 4). Despite
using high concentration of siRNA, there was no detectable knockdown of ACBD3 (Figure
3-4). This may not be a surprise as primary macrophages are particularly challenging to
transfect as the transfection reagent and the transfected nucleic acid are often recognized
and result in macrophage activation and degradation of the transfected nucleic acids [369].
Alternatively, we used the same siRNA pools to partially knockdown expression of
ACBD3 in HEK293T (Figure 3-5). Optimization for DharmaFECT transfection reagent
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was determined as recommended per manufacturer and the maximum recommended
volume (µL) of reagent was needed to effectively silence ACBD3 in HEK293T cells.

Figure 3-3: Localization of ACBD3 to the LCV during infection of hMDMs.
Representative confocal microscopy images of Co-localization of the LCVs containing
wild type, ΔT4SS mutant, mavE mutant, or the complemented strain (mavE/C) labeled
with anti-ACBD3 (red), DAPI (blue) and anti-Legionella (green). Quantification of colocalization with the LCV (indicated by arrowheads and yellow in color) is shown in
merged images. The results are representative of three independent experiments
performed in triplicate.
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Figure 3-4: Western Blot Analysis of Silencing of host protein ACBD3 in hMDMs.
Human monocyte derived macrophages were treated with ACBD3 RNAi for 24 hours.
Knockdown was determined by immunoblotting of cellular lysates with anti-ACBD3
polyclonal antibody. Results are representative of three independent experiments.

Figure 3-5: Western Blot Analysis of Silencing of host protein ACBD3 in HEK293T
cells. HEK293T cells were treated with ACBD3 RNAi for 24 hours at varying volumes of
DharmaFECT transfection reagent and maximum recommended siRNA volume.
Knockdown was determined by immunoblotting of cellular lysates with anti-ACBD3
polyclonal antibody. Results are representative of three independent experiments. A total
of 100 infected cells for each replicate were counted for presence or absence of localization.
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Co-localization of ACBD3 during siRNA knockdown
We examined sub-cellular localization of ACBD3 in HEK293T cells. Consistent
with localization of ACBD3 to the LCV in hMDMs, ACBD3 localized to the LCV
harboring the WT strain of L. pneumophila and the complemented strain (mavE/C) at
both 1-hour and 10-hour post infection in HEK293T cells (Figure 3-6). At 1-hour post
infection, 93% of the LCVs harboring WT bacteria co-localized with ACBD3, while 19%
of the mavE mutant containing LCVs co-localized with ACBD3 (Figure 3-6A). The
defect of the mavE mutant was restored upon complementation where 87% of the
vacuoles co-localized with ACBD3. Much like the mavE mutant strain-containing LCVs,
13% of the ΔT4SS mutant vacuoles co-localized with ACBD3 (Figure 3-6A). Similar
results were observed 10-hours post infection in HEK293T cells. The data showed that
in HEK293T cells, 97% of LCVs harboring wild type bacteria co-localized with ACBD3,
while only 17% and 17% of the mavE mutant and ΔT4SS mutant-containing vacuoles,
respectively, co-localized with the ACBD3 (Figure 3-7A). Much like WT-containing
LCVs, 92% of the complemented mutant (mavE/C) containing LCVs co-localized with
ACBD3. Thus, in both hMDMs and HEK293T cells, ACBD3 is co-localized with the
LCV in a MavE-dependent manner.
HEK293T cells were transfected with either the optimized ON-TARGETplus
Human ACBD3 siRNA pool or non-targeting pool 24 hours prior to WT, mavE mutant,
mavE/C, and ΔT4SS bacterial infection to knockdown expression of ACBD3.
Unfortunately, ACBD3 was not co-localized with the LCV in the scramble control or the
siRNA knockdown at both 1-hour post infection or 10-hour post infection. Thus, there
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was likely a side effect of the transfection reagent on co-localization of ACBD3 to the
LCV (Figure 3-6B,C and 3-7B,C).

Figure 3-6: Localization of ACBD3 to the LCV during infection of HEK293T cells 1
hour post infection. Representative confocal microscopy images of Co-localization of the
LCVs containing wild type, ΔT4SS mutant L. pneumophila, mavE mutant, or the
complemented strain (mavE/C) labeled with anti-ACBD3 (red), DAPI (blue) and antiLegionella (green). Quantification of co-localization with the LCV (indicated by
arrowheads and yellow in color) is shown in merged images. ND indicates not detectable.
(A) 1-Hour Infection of HEK293T cells (B) 1-hour Infection of HEK293T cells treated
with non-targeting siRNA pool for 24 hours prior to infection. (C) 1-hour Infection of
HEK293T cells treated with ACBD3 siRNA pool for 24 prior to infection. Results are
representative of three independent experiments. A total of 100 infected cells for each
replicate were counted for presence or absence of localization.

84

Figure 3-7: Localization of ACBD3 to the LCV during infection of HEK293T cells 10hours post infection. Representative confocal microscopy images of Co-localization of
the LCVs containing wild type, ΔT4SS mutant L. pneumophila, mavE mutant, or the
complemented strain (mavE/C) labeled with anti-ACBD3 (red), DAPI (blue) and antiLegionella (green). Quantification of co-localization with the LCV (indicated by
arrowheads and yellow in color) is shown in merged images. ND indicates not detectable.
(A) 10-hour Infection of HEK293T cells. (B) 10-hour Infection of HEK293T cells treated
with non-targeting siRNA pool for 24 hours prior to infection. (C) 10-hour Infection of
HEK293T cells treated with ACBD3 siRNA pool for 24 prior to infection. Results are
representative of three independent experiments. A total of 100 infected cells for each
replicate were counted for presence or absence of localization.
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Role of MavE on intracellular replication of L. pneumophila in HEK293T cells
Since the mavE mutant was previously shown to be defective for intracellular
growth in hMDMs and amoeba, we determined if the mavE mutant also showed attenuation
in intracellular growth in HEK293T cells. The data showed that the mavE mutant did not
exhibit a defective phenotype in HEK293T and grew similar to the WT strain. The
translocation-deficient ΔT4SS mutant control failed to grow in HEK293T cells (Figure 38). These data indicate that HEK293T cells are not useful to determine the role of MavEACBD3 interaction in LCV biogenesis. This emphasizes the importance of our approach
in using primary hMDMs throughout our studies.

Figure 3-8: The mavE mutant is not attenuated within HEK293T cells. To determine
intracellular replication of the WT strain, the T4SS mutant, the mavE mutant, and
complemented mavE mutant (mavE/C), HEK293T cells were infected and number of
CFUs was determined at 2, 12 and 24 h post-infection. Data points represent (mean
CFUs ± SD, n = 3) and are representative of three independent experiments. (Student ttest, * p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001)

86

Discussion
Modulation of host cell processes is essential for the biogenesis of the LCV. The
effector protein MavE potentially interacts with the host ACBD3 protein.

ACBD3

maintains Golgi structure by interacting with giantin, affects transport between the ER and
Golgi, and recruits PI4KB to the Golgi membrane, enhancing its enzymatic activity by
increasing its local concentration [357, 370]. Protein transport from the ER to the Golgi
compartments is mediated by small vesicles and requires a number of proteins, including
coat protein complex (COPI and COPII) and GTPases ARF and Sar1p [371-373]. The
effector protein, LotB, a Legionella deubiquitinase modulates the early secretory pathway
by interacting with COPI vesicles when ectopically expressed [374]. The RalF effector
functions as a GEF to recruit the ADP-ribosylation factor 1 (Arf1) to the LCV, enabling
the GEF-like RalF effector to modulate membrane transport in the secretory pathway [243,
250]. Additionally, the DrrA/SidM effector preferentially recruits Rab1 and tethers ERderived vesicles to the LCV, mediated by another L. pneumophila effector, LidA [166].
DrrA/SidM may compete with endogenous guanine nucleotide exchange factors (GEFs) to
redirect Rab1 from its normal secretory intracellular localization to plasma membranederived vesicles [251]. The LepB effector accumulates on the LCV as DrrA/SidM and
Rab1 cycle off and has been shown to function as a GTPase activating protein (GAP) for
Rab1 (Figure 1-3) [196, 252].

The arsenal of effector proteins of Legionella employs

multiple biochemical mechanisms to prevail over a diverse array of host cell processes.
While MavE may not be the only effector protein to interact with ACBD3, localization of
ACBD3 to the LCV is MavE dependent (Figure 3-3). MavE does harbor a eukaryotic
NPxY motif that in eukaryotic cells binds with phosphotyrosine-binding domains present
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on signaling and adaptor eukaryotic proteins.

This motif could be responsible for

binding/interaction with ACBD3. However, more studies are needed to determine the
ability of various substitution mutants of MavE within the NPxY motif and its vicinity to
interact with ACBD3.
Another peptide sequence fragment was identified unique to Isoform 2 of Rasrelated protein Rab-8A was present in both biological repeats of MavE-BioID2.
However, both samples had probabilities below the 95% confidence level (Table 2).
While small GTPases Rabs are key regulators of intracellular membrane trafficking,
further examination of this protein was not considered, because both biological repeats
showed a confidence probability below 95%. Other host proteins identified were solely
identified in only one biological repeat of MavE-BioID2 and further examination of
MavE interaction with AP-1 Complex subunit beta and Arfaptin-2 should be performed.
The AP-1 Complex subunit beta had a 100% probability and is a subunit of clathrinassociated adapter protein complex 1, playing a role in protein sorting in the lateGolgi/trans-Golgi network and/or endosomes [375]. Another biotinylated host-MavE
interacting protein identified by mass spectrometry with a high probability of
identification was Arfaptin-2. Arfaptin-2 plays a possible important function in vesicle
biogenesis and is involved in autophagy by regulating the starvation-dependent
trafficking of ARG9A vesicles which deliver PI4KB to membranes [376, 377].
Silencing of host protein ACBD3 in hMDMs proved to be exceptionally
challenging. Another approach that can be used in the future is Magnetofection [378].
This method uses a magnetic field to concentrate the magnetic nanoparticles combined
with gene vectors (siRNA) onto the cell surface. The cells take up the genetic material
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naturally via endocytosis or pinocytosis, keeping membrane architecture and structure
intact [378]. Co-localization of ACBD3 to the LCV was lost upon the silencing of ACBD3
and control siRNA in HEK293T cells in WT strain infected cells. DharmaFECT
composition is proprietary and may compromise ACBD3 function via Golgi membrane
permeabilization. Therefore, future studies using the Magnetofection method for
transfecting hMDMs with ACBD3 RNAi may also avoid the possible impact of the
DharmaFECT transfection reagent.
While the MavE effector is indispensable for intracellular replication of L.
pneumophila in macrophages and amoeba, it is dispensable within the HEK293T cell line.
While the HEK293 cells are useful in research and can be used for a variety of applications,
they are not phagocytic cells and not naturally infected by L. pneumophila. Thus, L.
pneumophila effectors may not have the same effect in transformed cell lines compared to
primary cells. The use of hMDMs throughout most of the studies strengthens the rigor of
our approach. We conclude that our data suggests MavE interacts with host protein
ACBD3, but substantial follow up experiments need to be performed. We have developed
a working model of the function of MavE during infection of hMDMs (Figure 3-9).
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Figure 3-9. Working Model of MavE-ACBD3 Interaction in macrophages. MavE
(red) is involved in the acquisition of ER-derived vesicles by the LCV and in evasion of
lysosomal fusion. It is likely that both functions depend on the NPxY motif (yellow)
located within the MavE structure. By mediating interactions with adaptor proteins, the
NPxY motif of MavE may coordinate LCV trafficking through interaction with host
adapter protein, ACDB3 (blue) and other L. pneumophila metaeffectors enabling ER
remodeling and facilitating lysosomal evasion. ACBD3 recruits PI4KB and along with the
PI4K2A enzyme, PI4KB synthesizes the phosphatidylinositol-4-phosphate (PI4P) lipid.
L. pneumophila exploits PI4P to anchor secreted effector proteins to the LCV [362].
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Materials and Methods
Cell lines
For infections of cell monolayers, L. pneumophila was grown in BCYE agar
plates with appropriate antibiotic selection at 37°C for 3 days prior to use in infections, as
described previously [337]. Human monocyte-derived macrophages (hMDMs) were
isolated from healthy donors and cultured in RPMI 1640 (Corning Cellgro) as described
previously [337, 338]. HEK293T cells (ATCC) were cultured in DMEM (Gibco)
supplemented with 10% fetal bovine serum as previously described [337, 338]. All
methods were carried out and approved in accordance with the University of Louisville
Institutional Review Board guidelines and blood donors gave informed consent as
required by the University of Louisville Institutional Review Board (IRB # 04.0358).
TABLE 3
Primers used in this studya
Primerb
Orientationc

Sequence

Primers used for cloning into the pacGFP1-C1 vector for eukaryotic expression
GFP mavE

F

GTCGACCTGACTCGATTCATAATGC

GFP mavE

R

AAGCTTTTATGGTTTGTTGCCAAAC

Primers used for cloning into the pmycBioID2-13x vector for eukaryotic expression
mycBioID2-MavE xho1

F

ctcgagCTGACTCGATTCATAATGC

mycBioID2-MavE kpn1

R

ggtaccTTATGGTTTGTTGCCAAACA

a

All primers are 5′-phosphorylated.
KO, knockout.
c
F, forward; R, reverse.
b

To identify the Protein: Protein interactions of the MavE protein
We utilized a modified method derived from the previously reported BioID
screens [367, 379-381]. Approximately 3x107 HEK293 cells were cultured as 80%
confluent monolayers under normal conditions prior to transfection with either pBioID2
only, or pMavE-BioID2 (Table 3) and supplemented with 1μM biotin. After a 24-hour
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transfection, the tissue culture cells were washed with 1xPBS, and whole cell lysates
were generated via the addition of Lysis Buffer (50mM Tris, pH 7.6; 500mM NaCl; 0.4%
Sodium Dodecyl Sulfate (SDS); 1mM DiThioThreitol (DTT); and 2.0% Triton X-100).
The whole cell lysates were vortexed and frozen to ensure complete lysis, and the lysates
were stored at -80ºC until ready for further use. To confirm the BioID2 biotin ligase was
function and labeling was specific we assessed the whole cell lysates using SDS-PAGE
and Western Blotting techniques. Equal amounts of whole cell lysates were resolved via
8% SDS-PAGE and blotted to PVDF membranes. The blotted proteins were probed for
protein biotinylation using streptavidin-HRP, or with anti-216 cMyc monoclonal
antibodies to detect the individual expressed BioID2 fusion proteins.
Streptavidin-Biotinylated protein purification
Whole cell lysates were thawed on ice prior to being vigorously vortexed and
clarified via centrifugation at 16,000xg for 5 minutes. The clarified whole cell lysates
were transferred to a fresh microfuge tube and incubated with magnetic streptavidin
beads for one hour at room temperature on a rotisserie mixer. After binding, the
supernatant was removed and discarded, and the magnetic beads were washed 5 times
with Lysis Buffer (50mM Tris, pH 7.6; 500mM NaCl; 0.4% Sodium Dodecyl Sulfate
(SDS); 1mM DiThioThreitol (DTT); and 2.0% Triton X-100) to remove unbound
proteins and nonspecific contaminants. The bound proteins were then released from the
streptavidin resin via resuspension in 100µL 2x Laemmli buffer and a 15-minute
incubation at 95ºC. The eluted proteins were transferred to a fresh microfuge tube and
precipitated with 25 µL 100% (w/v) TriChloroactic Acid (TCA). The samples were
vortexed, and samples were incubated on ice for 10 minutes to allow complete
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precipitation of the macromolecules in the solution. The precipitated proteins were
pelleted via 5 minutes of centrifugation at 16,000xg at 4ᵒC, and the supernatant was
decanted into an appropriate waste container. The protein pellet was washed three times
with ice cold acetone and again pelleted via 5 minutes of centrifugation at 16,000xg at
4ᵒC. After the final wash, the pellet was dried by incubating the microfuge tube at 95ºC
for 5 minutes to drive off excess acetone. The dried proteins were stored at -80ᵒC until
mass spectrometry was performed.
Identification of MavE Interactions by Mass Spectrometry [382, 383]
8µL of LC-MS grade water (ThermoFisher Scientific, Waltham, MA, USA) and
2µL of 1M triethylammonium bicarbonate pH8.5 (Honeywell, Charlotte, NC, USA) were
added to the dried purified protein samples. 2.5µL 25mM dithiothreitol (Sigma-Aldrich,
St. Louis, MO, USA) in water was added, and the samples were incubated at 65°C for
30min. 2.5µL of 60mM iodoacetamide (Sigma-Aldrich) in water was added, and the
samples were incubated at room temperature for 30min in the dark. 0.1µg of Pierce
Trypsin, MS Grade (ThermoFisher) in 2.5µL water was added; the samples were
incubated at 37°C for 30min. An additional 0.1µg trypsin was added, and the samples
were incubated overnight at 37°C. After digestion, the samples were dried in a SpeedVac
and stored at -80°C. The following protocol was used to prepare the samples for LC-MS
analysis:
Cleanup with C18 PROTOTM, 300Å Ultra MicroSpin Column
Solvents A=2% v/v acetonitrile / 0.1% v/v formic acid and B=80% v/v acetonitrile /
0.1% v/v formic acid were made and 100µL of solvent A used to dissolve the dried
sample. The solution was placed a spin column with the adapter collar into a 2mL
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microtube (empty this waste tube as needed). 100µL solvent B was added to the spin
column and centrifuged at 110xg for 2min; this was repeated twice. The waste tube was
emptied and 100µL solvent A was added to the spin column and centrifuged at 110xg for
2 mins and repeated twice. The liquid from the waste tube was transferred back into the
column and sample is passed through the column for a second time. The waste tube was
again emptied and 100µL of solvent A added, and centrifuge as above; repeat twice. The
column was placed in a clean 2mL microtube and 100µL of solvent B added and
centrifuged as above; this was repeated twice. The microtube was capped and frozen at 80°C for at least 30min. The eluate was dried in a SpeedVac (cap removed before
drying), and the dried residue was dissolved in 20µL solution A. 2µL (1/10 th) of each
dissolved sample was analyzed on the Orbitrap Elite.
Liquid Chromatography
The columns used were an Acclaim PepMap 100 75µm x 2cm, nanoViper (C18,
3µm, 100Å) trap, and an Acclaim PepMap RSLC 75µm x 50cm, nanoViper (C18, 2µm,
100Å) separating column (ThermoFisher) heated at 50°C. An EASY-nLC 1000 UHPLC
system (ThermoFisher) was used with solvents A = 2% v/v acetonitrile / 0.1% v/v formic
acid and B = 80% v/v acetonitrile / 0.1% v/v formic acid. Following injection onto the
trap, the sample was separated with a 165min linear gradient from 0% to 55% B at
250nL/min, followed by a 5min linear gradient from 55% to 95% B with a flow ramp
from 250 to 300nL/min, and lastly a 10min wash with 95% B at 300nL/min.

A 40mm

stainless steel emitter (ThermoFisher) was coupled to the outlet of the separating column.
A Nanospray Flex source (ThermoFisher) was used to position the end of the emitter near
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the ion transfer capillary of the mass spectrometer. The ion transfer capillary temperature
was set at 225°C, and the spray voltage at 1.75kV.
Data Acquisition
An Orbitrap Elite – ETD mass spectrometer (ThermoFisher) was used to collect
data from the LC eluate. An Nth Order Double Play was created in Xcalibur v2.2
(ThermoFisher). Scan event one obtained an FTMS MS1 scan (normal mass range;
240,000 resolution, full scan type, positive polarity, profile data type) for the range 3002000m/z. Scan event two obtained ITMS MS2 scans (normal mass range, rapid scan
rate, centroid data type) on up to twenty peaks that had a minimum signal threshold of
5,000 counts from scan event one. The lock mass option was enabled (0% lock mass
abundance) using the 371.101236m/z polysiloxane peak as an internal calibrant.
Data Analysis with Proteome Discoverer v2.4.0.305 and Scaffold Q+S v5.1.0
Proteome Discoverer v2.4.0.305 (ThermoFisher) was used to analyze the data.
The UniprotKB reviewed reference canonical proteomes were concatenated from Homo
sapiens (Proteome ID UP000005640) and L. pneumophila (Proteome ID UP000000609)
for the Mascot v2.5.1 (Matrix Science Inc, Boston, MA, USA) and SequestHT searches.
The enzyme specified was trypsin (maximum two missed cleavages with inhibition by
Proline) with Carbamidomethyl(C) as a static modification and Oxidation(M), Biotin(K)
as dynamic. Fragment tolerance was 1.0Da (monoisotopic) and parent tolerance was
50ppm (monoisotopic). A Target Decoy PSM Validator node was included in the
Proteome Discoverer workflow.
Scaffold (version Scaffold_5.0.0, Proteome Software Inc., Portland, OR) was
used to validate MS/MS based peptide and protein identifications. Peptide identifications
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were accepted if they could be established at greater than 99.9% probability by the
Scaffold Local FDR algorithm. Protein identifications were accepted if they could be
established at greater than 99.9% probability and contained at least 1 identified peptide.
Protein probabilities were assigned by the Protein Prophet algorithm [384]Proteins that
contained similar peptides and could not be differentiated based on MS/MS analysis
alone were grouped to satisfy the principles of parsimony. Proteins sharing significant
peptide evidence were grouped into clusters. Proteins were annotated with GO terms
from goa_human.gaf [385].
Transfection of HEK-293 cells (ATCC)
The mavE gene was cloned into the mammalian expression vector, pAcGFP1C1(Clontech). To generate the mavE-9L10P/AA allele, the wild type pAcGFP1-C1 MavE
plasmid was used as a template for PCR based site directed mutagenesis (Table 3).
HEK293T (ATCC) cells were grown to ~70% confluent and plated onto poly-L-lysinetreated 24 well plates. Following 24 h of incubation, HEK293T cell monolayers were
transfected with ~2 µg of plasmid DNA/well by using polyethylenimine (Polysciences)
and OptiMem (Gibco) for 24 h, following the manufacturer's recommendations (Roche)
as previously described [341, 342, 386].
Antibodies and western blot analysis
Immunoprecipitated proteins were heated at 99°C for 5 minutes in 2x Laemmli
sample buffer and loaded into mini-PROTEAN TGX precast gels separated by 10% SDSPAGE (BioRad) and transferred onto a polyvinylidene difluoride (PVDF) (BioRad)
membrane into the Trans-Blot Turbon Transfer System, by first wetting the nitrocellulose
membrane in 1xTransfer Buffer for 2-3 minutes and then immersing in 100% ethanol for
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2-3 minutes. Two ion reservoir stacks were also immersed in the transfer buffer for 2-3
minutes. One wetted stack was placed on the bottom of the cassette, serving as the
bottom ion reservoir, the wetted PVDF membrane was placed on top of the wetted stack
with the gel membrane directly on top. A second wetted transfer stack was placed on top
of the gel and the cassette lid was closed and locked and transfer was initiated at 2.5A
constant; up to 25V for mixed molecular weight. To perform antibody binding, the iBind
Flex Solution Kit was used. The transferred PVDF membrane was immersed in 10mL of
1x iBind Flex solution and placed protein side down on the previously wetted iBind Flex
card. The diluted 1ᵒ antibody was prepared and placed in row 1, 1x iBind Flex solution in
row 2, diluted 2ᵒ antibody in row 3 and 1x iBind Flex solution placed in row 4. The
iBind Flex device was closed and the device left undisturbed until the well of row 4 was
empty. Rabbit polyclonal anti-ACBD3 (Invitrogen) was used at a dilution of 1:1000,
Rabbit-HRP was used at a dilution of 1:5000 (ThermoFisher). To detect the blot
proteins, Thermo Scientific SuperSignal West Femto was used as directed.
Intracellular replication in HEK293T
For infection of cell monolayers, L. pneumophila strains were grown in BYE
broth with appropriate antibiotic selection, at 37 °C with shaking, to post-exponential
phase (OD550nm 2.1–2.2). HEK293T (ATCC) were cultured in DMEM supplemented
with 10% fetal bovine serum, at 37 °C, as previously described [337]. The wild type
strain; the isogenic mutants, T4SS and mavE; and complement mavE/C were grown to
post-exponential phase in BYE broth at 37 °C with shaking prior to infection and used to
infect HEK293T cells as previously described [337, 338]. A total of 1 × 10 5 host cells
were plated in 96 well plates and infected with L. pneumophila at an MOI of 10. Plates
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were centrifuged at 200 × g (5 mins), to synchronize infection. After 1 h, cells were
treated with gentamicin to kill extracellular bacteria, as previously described [337, 338].
Over a 24 h time course, host cells were lysed with sterile water. L. pneumophila CFUs
were determined by plating serial dilutions onto BCYE agar.
RNAi Knockdown
Human ACBD3 (64746) siRNA SMARTpool targeting against four ACBD3
target sequences (Table 4) and scrambled non-targeting pool (Table 4) were resuspended
per horizon resuspension protocol to obtain 250µL, 20µM Stock solutions. These stocks
were then diluted to make 5µM siRNA working solutions using 1x siRNA buffer
purchased from Horizon. For 96 wells/plate: In tube 1 mix 0.5µL of 5µM siRNA and
9.5µL serum-free medium (RPMI for hMDMs/DMEM for HEK293T); in tube 2 mix
0.5µL DharmaFECT reagent and 9.5µL serum-free medium. Gently mix the contents of
each tube and incubate for 5 minutes at room temperature. Add the contents of tube 1 and
tube 2, gently mix and incubate for 20 minutes at room temperature, then add 80µL of
antibiotic-free complete medium (RPMI+10% FBS for hMDMs/DMEM+10% FBS for
HEK293T) for a total volume of 100µL. Remove culture medium from 96-well plate and
add 100µL transfection medium to each well. For 24wells/plate: In tube 1 mix 2.5µL of
5µM siRNA and 47.5µL serum-free medium (RPMI for hMDMs/DMEM for HEK293T);
in tube 2 mix 2.5µL DharmaFECT reagent and 47.5µL serum-free medium. Gently mix
the contents of each tube and incubate for 5 minutes at room temperature. Add the
contents of tube 1 and tube 2, gently mix and incubate for 20 minutes at room
temperature, then add 400µL of antibiotic-free complete medium (RPMI+10% FBS for
hMDMs/DMEM+10% FBS for HEK293T) for a total volume of 500µL. Remove culture
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medium from 24-well plate and add 500µL transfection medium to each well. Incubate
cells at 37ᵒC in 5% CO2 for 24-48hours. Transfection optimization was preformed to
obtain the highest transfection efficiency by varying the volume of DharmaFECT reagent
(0.5-2.5µL on 24 well plates).

TABLE 4
Dharmacon Product
siRNA

Target Sequence

ON-TARGET plus Non-targeting Pool, 5nmol
UGGUUUACAUGUCGACUAA
UGGUUUACAUGUUGUGUGA
UGGUUUACAUGUUUUCUGA
UGGUUUACAUGUUUUCCUA

Catalog Item: D-001810-10-05

ON-TARGET plus Human ACBD3 (64746) siRNA- SMARTpool, 5nmol
GGAUGCAGAUUCCGUGAUU
GCAACUGUACCAAGUAAUA
GCAUAUGGGAAGUAACAUU
GUAUAGAAACCAUGGAGUU

Catalog Item: L-010799-01-0005

DharmaFECT 1 Transfection Reagent, 0.2mL
Catalog Item: T-2001-01

Confocal microscopy
Processing of infected cells for confocal microscopy was performed as we
described previously [338]. Co-localization of the LCVs containing WT, ΔT4SS mutant,
mavE mutant; and complement mavE/C were analyzed for confocal following 1hr
infection in hMDMs and 1hr and 10hr infection in HEK293T cells. Cells were prepared
using the same protocol for intracellular replication except 1 x 10 5 host cells were plated
on coverslips in 24 well plates. The monolayers were infected with L. pneumophila at an
MOI of 10. Plates were centrifuged at 200 × g (5 mins), to synchronize infection. After
1 h, cells were treated with gentamicin to kill extracellular bacteria, as previously
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described [337, 338]. For all confocal experiments, cells were fixed in -20 ̊ C methanol
for 5 minutes and rinsed 3x in 10% PBS. For antibody labeling, goat anti-L.
pneumophila was used at a dilution of 1:500 and detected by Alexa-Fluor 488-conjugated
donkey anti-mouse IgG (1:1000) (Invitrogen, Carlsbad, CA) and rabbit polyclonal antiACBD3 (Invitrogen) was used at a dilution of 1:500 and detected by Alexa-Fluor 555conjugated donkey anti-rabbit IgG (1:1000) (Invitrogen, Carlsbad, CA). For antibody
labeling for localization, goat anti-L. pneumophila was used at a dilution of 1:750 and
detected by detected by Alexa-Fluor 488-conjugated donkey anti-goat IgG (1:1000)
(Invitrogen, Carlsbad, CA) rabbit polyclonal anti-ACBD3 (Invitrogen, Rockford, IL) was
used at a dilution of 1:500 and detected by Alexa-Fluor 555-conjugated donkey antiRabbit IgG (Invitrogen, Carlsbad, CA), DAPI was used for all experiments at a 1:5000
dilution. An Olympus FV1000 laser scanning confocal microscope was used in house to
examine cells as we described previously [298]. On average, 10–20 0.3 µm serial Z
sections of each image were captured and stored for further analyses, using Adobe
Photoshop CS3. A total of 100 infected cells for each replicate were counted for
presence or absence of localization.
Statistical analysis
All experiments were performed at least three independent biological replicates,
and the data shown are representatives of one experiment. To analyze for statistically
significant differences between three sets of data, the two-tailed Student’s t-test was used,
and the p-value was obtained. (* indicates p ≤ 0.05; ** indicates p ≤ 0.01; *** indicates p
≤ 0.001)
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CONCLUSIONS AND FUTURE DIRECTIONS
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The evolution of the pathogen to adapt to the intra-vacuolar environment of
eukaryotic cells and inter-kingdom as well as inter-bacterial horizontal gene transfer has
most likely shaped the long-term evolution of L. pneumophila with various protozoa as
the natural hosts. The ability of L. pneumophila to replicate intracellularly and survive is
totally dependent on interaction of the Dot/Icm translocated effectors with eukaryotic
host target proteins. Biogenesis of the replicative LCV involves remodeling the
Legionella-containing vacuole to an ER-derived LCV, that evades the endosomallysosomal degradation pathway [269]. It is important to note that the default endosomallysosomal degradation pathway is highly conserved throughout evolution, and the
Dot/Icm secretion system is indispensable for LCV biogenesis in macrophages as well as
amoeba. The data showing fusion of the vacuoles containing the mavE mutant with the
lysosome illustrates that the effector MavE is required for biogenesis of the LCV into an
ER-derived vacuole that evades lysosomal fusion [269]. Preliminary data suggests MavE
interacts with the host protein ACBD3, which is involved in Golgi-to-ER traffic, but still
needs to be confirmed. To further verify MavE-ACBD3 interaction, the reciprocal
pulldown of tagged ACBD3 and immunoblotted with anti-MavE antibody needs to be
performed.
Although many Dot/Icm-translocated effectors have been shown to directly
regulate the early secretory system of the host cell, except for VipD, no L. pneumophila
effector has ever been shown to be indispensable for evasion of the endosomal-lysosomal
degradation pathway. The VipD effector of L. pneumophila localizes to early endosomes
and interferes with endosomal trafficking through blocking interaction of Rab5 and
Rab22 with EEA1 [253]. VipD binds to the endosomal regulator Rab5 and triggers the
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hydrolytic phospholipase A1 activity of VipD, causing the removal of the lipid
phosphatidylinositol 3-phosphate facilitating endosomal lysosomal evasion by L.
pneumophilia [254]. However, only deletion of mavE results in severe impairment of
biogenesis of the LCV to an ER-derived vesicle that evades lysosomal fusion (Figure 24). We show that MavE is required for evasion of the default endosomal-lysosomal
degradation pathway and plays a crucial early role in the biogenesis of the nascent LCV
(Figure 2-6) [269]. It is not known whether ER-mediated remodeling or lysosomal
evasion is executed first during LCV biogenesis. We speculate that it is likely that early
and rapid MavE-mediated recruitment of ER-derived vesicles through MavE-ACBD3
interaction prevents traveling to the default endosomal-lysosomal pathway.
To identify inter-substrate physical interactions of effector-effector suppression
pairs in L. pneumophila a yeast two-hybrid assay and LUMIER assay that detects direct
protein-protein interactions showed MavE and the effector YlfA/LegC7 interact [191].
YlfA/LegC7 along with two other effectors (LegC2 & LegC3) assemble in a complex on
the LCV and interact with ER-derived vesicles to initiate membrane fusion [190, 191,
266-268]. We attempted to reproduce this interaction by co-immunoprecipitation of
tagged proteins of LegC2, LegC3 and LegC7 and MavE in HEK293T cells, along with
the reciprocal tagged proteins. Unfortunately, LegC7 did not interact with MavE, and
biological repeats did not reproduce this possible interaction between LegC7 and MavE.
Our collaborators, Dr. Miroslaw Cygler and Dr. Kevin Voth, who resolved the crystal
structure of MavE also tried to reproduce the LegC7 and MavE interaction in vitro using
pulldown assays without success [387]. By performing the BioID2 proximity labeling
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during infection of host cells, this should decipher possible interaction between LegC7
and MavE as previously published using a yeast two-hybrid assay and LUMIER assay.
Identification of MavE-interacting host proteins was determined by proximitydependent cellular biotinylation of neighboring proteins during ectopic expression of
MavE. While ACBD3 was not the sole protein identified by BioID2, it was the only one
found in both biological repeats and in one of the biological repeats it had a 98%
probability of identification (above the confidence level of 95%). ACBD3 recruits
PI4KB to the Golgi apparatus and with the enzyme PI4K2A, synthesizes PI4P [355, 357359]. PI4P is an essential lipid found in multiple membrane compartments of the Golgi,
trans-Golgi network (TGN), plasma membrane, endocytic compartments, and the LCV
[357, 362]. L. pneumophila exploits PI4P to anchor other injected effector proteins to the
LCV to subvert host cell PI metabolism which is essential for establishment of the
replicative LCV [362]. Determining if MavE interacts with PI4P or PI4KB could further
expand our knowledge of the interaction of MavE with ACBD3 and ultimately provide a
previously unknown link in vacuolar biogenesis of the LCV.
However, examination of MavE interaction with Arfaptin-2 and AP-1 Complex
subunit beta should be performed as both were identified as having high probabilities of
identification in one biological repeat. Identifying MavE-interacting host proteins
BioID2 assay in both human and amoebal cells would be beneficial, as modulation of
host cell functions and metaeffector activity could be different in various hosts. Again,
determining the interactions of MavE with other proteins during infection of host cells by
constructing a BioID2 plasmid that can be expressed in WT and the T4SS mutant L.
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pneumophila, will clarify any potential MavE-interacting metaeffectors that modulate
activity of the MavE effector, as function could vary between cell types.
The resolved crystal structure of MavE revealed an NPxY motif located on a
poorly defined electron density loop with flexibility that may accommodate proteinprotein interactions (Figure 2-8). Eukaryotic NPxY motifs (Asp-Pro-x-Tyr) are a
conserved tyrosine phosphorylation motif that binds phosphotyrosine-binding domains
(PTB) present on signaling and adaptor eukaryotic proteins [388]. Substitution of proline
in the NPxY motif and substitution mutant aspartic acid within the predicted protease
catalytic triad resulted in attenuation of L. pneumophila in hMDMs (Figure 2-9A). An
additional substitution mutant H68A (Histidine) also showed attenuation in A. polyphaga
(Figure 2-9B). Interestingly, both aspartic acid and histidine can be phosphorylated.
Histidine phosphorylation is crucial in prokaryotes and accounts for roughly 6% of total
phosphorylation in eukaryotes [389]. All substitution mutants in the NPxY were changed
to alanine. Interestingly, changing the aliphatic proline to aliphatic alanine showed
attenuation in both hMDMs and amoeba. However, the aromatic tyrosine, that is capable
of being phosphorylated did not show attenuation.
In theory the tyrosine found within the NPxY motif may be phosphorylated
during infection, but its substitution had no effect on the function of MavE and
intracellular growth of L. pneumophila. This may indicate that the tyrosine residue
within NPxY does not have an effect on MavE. Alternatively, tyrosines within close
proximity of the NPxY motif may become phosphorylated. However, ACBD3 does not
contain a PTB site, suggesting no role for the tyrosine residue within the NPxY motif in
MavE-interaction with ACBD3. Future studies generating substitutions in the tyrosine
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residues in close proximity to the NPxY motif to glutamic acid (E) would result in a
negatively charged region, as previously reported as an analogous substitution for
phosphotyrosine [390]. It would also be useful to determine if the expression of the
already generated substitution mutants in the NPxY motif of MavE interact with ACBD3.
Demonstrating if the NPxY motif or the tyrosine-based sorting motifs are responsible for
the interaction of MavE and host protein ACBD3 and would further characterize the role
of the NPxY motif of MavE in vacuolar biogenesis.
Additionally, protein phosphorylation is the most widespread type of posttranslational modification affecting multiple cellular processes and plays a critical
regulatory role in protein-protein interactions [391]. Protein kinases catalyze the transfer
of γ-phosphate from ATP to specific potentially phosphorylatable residues including the
structure of catalytic sites [391]. Determining if MavE or the NPxY substitution mutants
are phosphorylated by ectopically expressing the constructs in HEK293T cells and
immunoblotting with anti-phosphotyrosine antibody would selectively identify the
tyrosine-phosphorylated peptides. To examine all residue phosphorylation of MavE,
phosphorylation site mapping with tandem mass spectrometry would measure
phosphorylated peptides within MavE, further identifying the protein’s function.
Overall, we have identified a key effector utilized by L. pneumophila to remodel
the LCV to an ER-derived vacuole and evade the default endosomal-lysosomal pathway
(Figure 3-9). Importantly, this effector is required by L. pneumophila in both the natural
amoebal hosts and the accidental host, the human macrophage, reflecting the high
evolutionary conservation of the default endosomal-lysosomal pathway across
eukaryotes.
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